Malignant neoplasm of breast, HER-negative

C3_BREAST_ERNEG

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions not RX_ERPLUS	294747
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C50 Cause of death: ICD-9 — 174 Cause of death: ICD-8 — 174 Cancer registry: Topography ICD-O-3 — C50 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — [23] 2 out of 7 registries used, show all original rules.	10029
4. Check minimum number of events None	10029
5. Include endpoints None	10029
6. Filter based on genotype QC (FinnGen only)	9044

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE
Control conditions: not RX_ERPLUS

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF9

NAME	C3_BREAST_ERNEG
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!RX_ERPLUS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS	!RX_ERPLUS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C50
COD_ICD_9	174
COD_ICD_8	174
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C50
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	[23]

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of breast, HER-negative based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9044	9044	-
Unadjusted period prevalence (%)	3.21	3.21	-
Median age at first event (years)	58.69	58.69	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9342: Matched controls
89686

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WF049

NOMESCO Finland

Radiotherapy of metastasis

634.5

320.0

320

A79

ICPC

Malignancy NOS

91.8

311.6

169

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

307.7

1102

HA1HA

NOMESCO Finland

Tomosynthesis mammography

38.2

307.7

229

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

307.7

369

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

6.5

307.7

676

1065

HAE99

NOMESCO Finland

Other reconstruction of breast

83.8

307.7

393

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

307.7

543

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

9.8

307.7

806

857

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

97.8

307.7

296

HA1AA

NOMESCO Finland

X-ray mammography

22.4

307.7

3469

2304

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

130.8

307.7

832

Z31.5

ICD-10 Finland

Genetic counselling

7.8

307.7

1107

1528

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

52.8

307.7

215

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.7

307.7

2905

9806

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

307.7

830

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

307.7

1152

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

3147.3

307.7

2927

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

2311.4

307.7

914

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

40.1

307.7

240

D70.82

ICD-10 Finland

Drug-induced neutropenia

26.4

307.7

247

JN4AD

NOMESCO Finland

Body CT examination

4.5

307.7

1072

2515

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

136.9

307.7

396

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

307.7

3594

C50.99

ICD-10 Finland

Breast, unspecified

2399.9

307.7

1738

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

90.8

307.7

416

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

25.7

307.7

455

178

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

53.7

307.7

319

XX1XN

NOMESCO Finland

Other isotope examination

1890.7

307.7

397

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

307.7

703

A03FA01

ATC

metoclopramide; systemic, rectal

5.7

307.7

3558

8752

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

407

C50

ICD-10 Finland

Malignant neoplasm of breast

2315.6

307.7

1352

A04AA01

ATC

ondansetron; systemic, rectal

7.0

307.7

1188

1822

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

19.6

307.7

356

181

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

107.7

307.7

2292

270

L01BC06

ATC

capecitabine; oral

+∞

307.7

792

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

307.7

456

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

307.7

1011

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

8.2

307.7

544

674

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

61.8

307.7

353

ZZF00

NOMESCO Finland

Graft of adipose tissue

36.0

307.7

270

XX3DW

NOMESCO Finland

Time consuming IT work

12.9

307.7

2080

1944

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

18.4

307.7

594

329

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

14401.1

307.7

1304

9703

FHL

Breast resection

14.2

307.7

363

255

A04AA02

ATC

granisetron; systemic, transdermal

361.4

307.7

1241

WX402

NOMESCO Finland

General anaesthesia

3.0

307.7

2621

10387

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

37.7

307.7

278

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

71.1

307.7

1444

230

ZZR10

NOMESCO Finland

Flap of skin and muscle

99.8

307.7

292

N63

ICD-10 Finland

Unspecified lump in breast

5.5

307.7

1658

3363

WF002

NOMESCO Finland

Radical radiotherapy

48.7

307.7

477

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

5620.9

307.7

1513

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

307.7

445

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

24.3

307.7

2838

1579

ZX090

NOMESCO Finland

Other technic of radiotherapy

478.2

307.7

649

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

307.7

455

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

307.7

1514

X76

ICPC

Malignant neoplasm breast female

1802.4

307.7

825

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

307.7

496

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2129.8

307.7

939

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

328.8

307.7

425

HAC20

NOMESCO Finland

Total mastectomy

1489.4

307.7

2241

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

1205.3

307.7

477

WZC00

NOMESCO Finland

Treatment plan or consultation

3.1

307.7

4340

19524

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

6.2

307.7

910

1535

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

57.0

307.7

642

116

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

140.9

307.7

243

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

33.6

307.7

232

HAB99

NOMESCO Finland

Other partial excision of mammary gland

32.1

307.7

1118

378

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

307.7

481

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

40.4

307.7

218

L03AA13

ATC

pegfilgrastim; parenteral

2532.2

307.7

1209

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

53.7

307.7

458

HAB40

NOMESCO Finland

Wedge excision of mammary gland

208.0

307.7

3408

247

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

108.6

307.7

221

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

307.7

367

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

3713.8

307.7

735

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

434.8

307.7

473

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

307.7

418

H02AB02

ATC

dexamethasone; systemic

57.3

307.7

2554

585

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

4008.7

307.7

1137

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

634.6

307.7

1769

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

36.4

307.7

895

260

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

521.2

307.7

703

L03AA02

ATC

filgrastim; parenteral

174.6

307.7

417

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

356

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

137.3

307.7

196

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

307.7

3746

115

Kela drug reimbursment

Breast cancer

+∞

307.7

3094

L02BG04

ATC

letrozole; oral

25.1

307.7

529

214

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

68.1

307.7

401

HAD99

NOMESCO Finland

Other plastic operation on breast

31.6

307.7

241

TQW20

NOMESCO Finland

Tatoe

198.6

307.7

582

WZC30

NOMESCO Finland

Teaching

3.1

307.7

1834

6568

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

5978.0

307.7

594

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

307.7

662

ZX080

NOMESCO Finland

Image guided radiotherapy

2001.6

307.7

555

PJA12

NOMESCO Finland

Sentinel node biopsy

5034.6

307.7

4822

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

240.3

307.7

407

TQB05

NOMESCO Finland

Puncture of skin of trunk

36.4

307.7

244

JN4BD

NOMESCO Finland

Extensive body CT

6.5

307.7

1031

1679

A04AA55

ATC

palonosetron, combinations; systemic

6047.1

307.7

1132

L02BA01

ATC

tamoxifen; oral

247.6

307.7

251

WF003

NOMESCO Finland

Adjuvant radiotherapy

520.3

307.7

748

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

1100.5

307.7

2260

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

4649.4

307.7

1651

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

1179.8

307.7

355

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

307.7

507

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

307.7

405

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

616.3

307.7

1079

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1892.3

307.7

857

5702

FHL

Local lymph node removal (eg armpit, groin)

84.8

307.7

182

A04AD12

ATC

aprepitant; systemic

624.0

307.7

494

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

26.9

307.7

238

NK6AN

NOMESCO Finland

Total body bone isotope imaging

62.0

307.7

414

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

37.0

307.7

244

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

422.2

307.7

877

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

307.7

816

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

307.4

298

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

52.9

293.1

173

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

37.2

290.9

186

Z51.5

ICD-10 Finland

Palliative care

4.5

282.9

734

1656

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2622.9

281.2

275

HAD40

NOMESCO Finland

Mastopexy

29.7

271.1

185

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

27.5

268.6

188

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

261.8

254

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

96.7

257.7

139

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.7

255.7

502

889

ZX112

NOMESCO Finland

Subcutaneous

12.0

255.1

265

218

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

252.5

245

HA4MT

NOMESCO Finland

Labeling mammary gland pathology with X-ray guidance

66.4

252.1

143

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

252.0

3781

21801

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

356.9

249.9

255

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

248.3

241

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

472.9

238.7

241

1CD02, ,

NOMESCO Finland

+∞

233.8

227

R4110

NOMESCO Finland

Physiotherapy

2.1

232.7

3012

16307

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

49.8

222.6

133

WZC15, ,

NOMESCO Finland

40.4

218.9

137

X21

ICPC

Breast sympt/compl female other

5.3

216.9

453

848

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

216.2

210

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

210.0

204

HAC25

NOMESCO Finland

Radical mastectomy

+∞

210.0

204

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

209.0

203

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

71.1

208.4

117

WX702

NOMESCO Finland

Supraglottic ventilation device

3.5

200.2

751

2195

HA1SA

NOMESCO Finland

Expansion mammography

45.3

198.5

121

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

31.3

196.8

132

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

280.4

192.7

199

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

45.1

190.1

116

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

19.4

188.6

151

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

95.1

181.2

ZX120

NOMESCO Finland

Intravenous

3.0

181.0

877

2987

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

180.1

175

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

180.1

175

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

177.0

172

FM1FN

NOMESCO Finland

Heart function isotope examination

1786.2

176.8

174

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

173.9

169

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

173.9

169

Z51.0

ICD-10 Finland

Radiotherapy session

292.4

172.7

178

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.6

171.6

594

1643

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

287.2

169.7

175

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

410.9

166.5

169

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

164.4

2336

12809

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

535.7

164.0

165

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

790.1

162.6

162

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

162.5

158

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

11.0

162.0

177

157

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

48.5

158.1

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

157.4

153

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

1558.2

157.3

155

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.7

153.9

521

1418

9706

FHL

Ablation mammae, includes axillary exploration

+∞

153.2

149

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

175.8

152.6

162

OAA41

NOMESCO Finland

Health check based on individual needs

69.4

152.5

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.1

151.9

666

2135

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

149.1

145

WF004

NOMESCO Finland

Palliative radiotherapy

250.9

148.3

154

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

147.1

143

XX2RW, ,

NOMESCO Finland

9.9

146.7

172

169

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

42.0

146.7

ZXA05

NOMESCO Finland

Left side

1.9

145.8

2596

15255

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

40.1

145.0

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

1417.7

144.9

143

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

1406.2

143.9

142

D05.0

ICD-10 Finland

Lobular carcinoma in situ

286.7

141.6

146

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

139.8

136

1749X

ICD-9 Finland

Malignant neoplasm of female breast, Breast (female), unspecified

+∞

139.8

136

ZXA00

NOMESCO Finland

Right side

1.8

137.1

2743

16658

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

32.3

135.4

ZX070

NOMESCO Finland

Intensity modified radiotherapy

174.2

134.6

143

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

133.6

130

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

35.8

131.6

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

131.6

128

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

131.6

128

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

131.6

128

HA1AE, ,

SPAT

3.4

129.7

500

1479

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

128.5

125

N64.9

ICD-10 Finland

Disorder of breast, unspecified

5.8

128.4

240

404

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

127.5

124

128

Kela drug reimbursment

Cancers of female genital organs

253.7

125.3

130

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

6.3

123.9

214

333

B01AB05

ATC

enoxaparin; parenteral

1.7

123.1

3024

19372

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

399.9

122.1

124

HAA10

NOMESCO Finland

Biopsy of mammary gland

7.2

121.9

184

248

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

16.8

121.8

104

JN4CD

NOMESCO Finland

Very extensive body CT

5.5

121.5

241

429

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

1156.2

120.3

119

L01CA04

ATC

vinorelbine; systemic

+∞

120.2

117

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

119.4

3637

24648

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

1146.4

119.2

118

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

239.3

118.2

123

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

239.3

118.2

123

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

118.2

115

9725

FHL

Reconstruction of the mammary gland with foreign material (after removal)

38.2

118.0

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

10.1

115.9

134

129

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

115.1

112

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

114.1

111

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

114.1

111

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

114.1

111

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

113.0

110

X26

ICPC

Fear of breast cancer female

7.9

112.9

158

195

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

147.1

112.5

121

X19

ICPC

Breast lump/mass female

4.5

112.3

283

619

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

111.9

4306

30812

WW500

NOMESCO Finland

Blood transfusion

4.5

110.9

282

621

HAD20

NOMESCO Finland

Liposuction of breast

31.1

110.1

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

109.9

107

JN6AD

NOMESCO Finland

CT of torso and neck

9.4

109.6

133

137

N02AA05

ATC

oxycodone; systemic

1.9

107.5

1588

8673

1XC03, ,

NOMESCO Finland

517.8

106.3

107

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

105.8

103

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

998.8

103.9

103

ZZR00

NOMESCO Finland

Flap of skin

9.9

102.3

120

118

D24

ICD-10 Finland

Benign neoplasm of breast

3.7

102.2

334

885

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.8

102.0

237

485

8500/2-C50.4

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast

+∞

101.7

HAD00

NOMESCO Finland

Augmentation mammoplasty

52.7

101.3

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.3

97.9

391

1180

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

97.6

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

47.5

97.6

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

96.6

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

+∞

96.6

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

41.4

96.2

PJA10

NOMESCO Finland

Exploration of lymph nodes

10.1

94.2

109

105

N64.5

ICD-10 Finland

Other signs and symptoms in breast

3.1

93.8

403

1271

9719

FHL

Other measure in this category

18.6

92.1

HA1DA

NOMESCO Finland

Restricted mammography

32.7

92.0

B01AB10

ATC

tinzaparin; parenteral

2.1

91.2

964

4660

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

89.4

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

89.4

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

29.5

89.1

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

88.3

1748X

ICD-9 Finland

Malignant neoplasm of female breast, Other specified sites of female breast

+∞

88.3

TQW99

NOMESCO Finland

Other minor procedure on skin

2.9

88.1

433

1474

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

87.3

HA1S1

NOMESCO Finland

Photography of breasts

103.5

86.5

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

86.4

889

4250

8510/3-C50.9

ICD-O-3

Medullary carcinoma, NOS, of breast, NOS

+∞

86.3

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

40.1

85.9

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

25.0

85.7

ZXE00

NOMESCO Finland

One hour or less

1.6

85.6

3460

24561

XX1AD

NOMESCO Finland

Other CT-examination

128.8

85.6

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

2.9

84.6

415

1411

WB610

NOMESCO Finland

Demanding neoadjuvant therapy of tumour with antibodies

+∞

83.2

1745A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-outer quadrant

+∞

83.2

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

+∞

82.2

QBJ00

NOMESCO Finland

Liposuction in trunk

8.8

82.0

105

116

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

21.8

80.1

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

78.0

L02BG06

ATC

exemestane; oral

+∞

78.0

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

37.1

78.0

N60.8

ICD-10 Finland

Other benign mammary dysplasias

7.9

77.8

108

132

G02CX06, ,

ATC

18.2

77.8

R50.9

ICD-10 Finland

Fever, unspecified

1.9

77.2

1154

6275

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

76.0

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

+∞

76.0

YX9AW, ,

NOMESCO Finland

132.4

75.7

PJW99

NOMESCO Finland

Other operation on lymphatic system

365.5

74.7

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

73.9

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

73.9

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

360.6

73.6

L01XX05

ATC

hydroxycarbamide; oral

20.0

73.5

XX9TE

NOMESCO Finland

Compementary ultrasound examination

7.3

73.5

109

144

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

242.1

72.3

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

22.7

72.0

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

71.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.2

71.8

294

900

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.0

70.9

155

301

N05CB02

ATC

barbiturates in combination with other drugs

2.7

70.8

412

1531

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.3

70.6

188

429

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.7

70.4

225

587

9702

FHL

Breast exploration and possible tumor removal

3.4

70.0

259

745

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

30.2

69.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

67.7

956

5091

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

37.7

67.2

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

225.7

67.2

8140/3-C50.9

ICD-O-3

Adenocarcinoma, NOS, of breast, NOS

+∞

66.7

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

66.4

991

5371

A04AA03

ATC

tropisetron; systemic

34.6

65.7

QBA00

NOMESCO Finland

Puncture of skin of trunk

10.7

65.1

D05.7

ICD-10 Finland

Other carcinoma in situ of breast

626.9

65.0

9724

FHL

Breast augmentation or reconstruction with own tissue

26.1

64.5

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

26.1

64.5

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

6.3

63.7

108

165

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

63.6

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

62.6

497

2132

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

8.4

62.6

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

62.2

796

4098

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

61.4

3747

28373

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

302.3

60.4

Z3231

NOMESCO Finland

Registered nurse

1.5

59.9

2216

15175

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

578.2

59.9

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.8

59.8

185

472

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

15.7

58.8

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

58.5

XX2VW

NOMESCO Finland

Radiologic consultation

6.6

58.4

139

ZSZ00

NOMESCO Finland

Primary repair operation

558.7

57.8

1743A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-inner quadrant

+∞

57.5

17409

ICD-8 Finland

Malignant neoplasm of breast, Unspecified

+∞

57.5

HA1BA

NOMESCO Finland

Extensive X-ray mammography

7.2

56.2

115

1741A

ICD-9 Finland

Malignant neoplasm of female breast, Central portion

+∞

55.4

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

55.4

WB321

NOMESCO Finland

Multiple adjuvant therapy of malignancy with biomodifiers

+∞

55.4

C50.09

ICD-10 Finland

Malignant tumor of nipple and areola, other or undeterminated histology

+∞

54.4

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

8.2

54.2

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

183.5

54.1

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

53.4

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

7.4

53.1

102

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.8

52.6

XX2ET, ,

NOMESCO Finland

+∞

52.3

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.3

52.1

136

306

Z31.6

ICD-10 Finland

General counselling and advice on procreation

9.2

52.1

S77

ICPC

Malignant neoplasm of skin

12.9

52.0

D05

ICD-10 Finland

Carcinoma in situ of breast

+∞

51.3

2393A

ICD-9 Finland

Neoplasm of unspecified nature, Breast

5.7

51.1

166

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

50.3

C56

ICD-10 Finland

Malignant neoplasm of ovary

106.2

49.9

Z3226

NOMESCO Finland

Physiotherapist

1.6

49.7

1528

9993

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

49.4

1715

11522

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

+∞

49.3

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

49.3

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

48.9

706

3773

N61

ICD-10 Finland

Inflammatory disorders of breast

2.8

48.6

243

834

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

241.5

48.3

A02BC02

ATC

pantoprazole; systemic

1.4

48.1

6415

54618

HA4BT

NOMESCO Finland

Breast seed implant placement under ultrasound guidance

164.1

48.1

S18

ICPC

Laceration/cut

1.4

48.0

4019

31712

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

236.4

47.3

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

11.8

47.2

8000/3-C50.9

ICD-O-3

Neoplasm, malignant of breast, NOS

+∞

47.2

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

47.2

3AA13, ,

NOMESCO Finland

+∞

47.2

N06AX16

ATC

venlafaxine; oral

1.6

46.7

1285

8183

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

451.6

46.6

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

46.2

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

157.6

46.1

N02BE01

ATC

paracetamol; systemic, rectal

1.7

45.9

8408

75712

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

45.4

321

1308

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

45.2

785

4431

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

44.9

261

969

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.9

44.8

579

2983

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.4

44.5

324

1338

N62

ICD-10 Finland

Hypertrophy of breast

2.1

44.5

447

2106

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

62.7

44.3

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

44.1

8211/3-C50.9

ICD-O-3

Tubular adenocarcinoma of breast, NOS

+∞

44.1

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

422.4

43.5

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

5.0

43.3

182

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.2

42.8

116

269

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

9.8

42.7

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

6.2

42.6

116

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

54.7

42.6

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

12.7

42.2

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

42.1

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

42.1

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

42.1

HA1AT, ,

SPAT

9.0

41.4

JAL30

NOMESCO Finland

Omentectomy

5.4

41.3

150

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

41.2

426

2028

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

41.0

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

41.0

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

41.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

40.9

678

3773

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

6.4

40.9

102

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

40.0

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

40.0

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

39.8

437

2126

D45

ICD-10 Finland

Polycythaemia vera

13.0

39.7

2330A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Breast

383.5

39.5

DHB00

NOMESCO Finland

Excision of lesion of external nose

8.4

39.3

L02BG03

ATC

anastrozole; oral

84.9

39.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

39.1

516

2675

J01MA12

ATC

levofloxacin; systemic

1.5

39.0

1362

9115

WX704

NOMESCO Finland

Intubation

1.8

38.9

645

3589

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

9.9

38.5

L57.0

ICD-10 Finland

Actinic keratosis

1.7

38.0

839

5047

156

Kela drug reimbursment

Lapatinib

+∞

38.0

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

36.9

C50.0

ICD-10 Finland

Malignant neoplasm: Nipple and areola

+∞

36.9

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.0

36.9

106

257

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

36.5

6048

51934

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.9

36.0

458

2345

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

+∞

35.9

9721

FHL

Mamilla reconstruction or transposition

47.1

35.9

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

7.1

35.7

C20

ICD-10 Finland

Malignant neoplasm of rectum

344.5

35.4

8500/2-C50.5

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast

+∞

34.9

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

34.9

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

6.5

34.9

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

334.8

34.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

334.8

34.4

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

34.2

260

1095

WF099

NOMESCO Finland

Other radiotherapy

9.2

34.2

C90.0

ICD-10 Finland

Multiple myeloma

118.9

34.1

SPAT1269

SPAT

Other puncture and/or drainage

5.9

34.0

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

33.9

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

33.9

B29

ICPC

Lymph/immune mech sympt/complt other

6.4

33.7

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

33.4

175

617

XW000

NOMESCO Finland

Bone marrow biopsy

2.6

33.4

192

710

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

325.1

33.4

C82.1

ICD-10 Finland

Follicular lymphoma grade II

325.1

33.4

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

33.2

662

3874

N64.8

ICD-10 Finland

Other specified disorders of breast

4.1

32.8

215

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

32.8

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

315.3

32.4

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.0

32.1

140

446

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

32.1

147

482

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.9

32.0

232

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

47.0

31.9

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

31.8

8211/3-C50.4

ICD-O-3

Tubular adenocarcinoma of upper-outer quadrant of breast

+∞

31.8

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

31.8

L01XE07

ATC

[U] lapatinib

+∞

31.8

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.6

31.8

186

694

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.5

31.8

204

796

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

159.0

31.2

R18

ICD-10 Finland

Ascites

3.4

31.1

111

313

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

30.8

ZSZ10

NOMESCO Finland

Secondary repair operation

67.3

30.3

J01DB01

ATC

cefalexin; oral

1.3

30.2

7237

64434

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

30.1

547

3120

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

30.1

233

989

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

8.5

30.0

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

29.8

1740A

ICD-9 Finland

Malignant neoplasm of female breast, Nipple and areola

+∞

29.8

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

29.8

WB131

NOMESCO Finland

Very demanding neoadjuvant cytostatic therapy

+∞

29.8

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

29.6

224

942

L02AE02

ATC

leuprorelin; implant, parenteral

3.7

29.5

250

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.7

29.4

165

603

9708

FHL

Radical mastectomy (Halsted), also involves removal of the parasternal gland

291.2

29.3

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

6.2

29.0

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

28.8

1729

12708

ZX050

NOMESCO Finland

Stereotactic radiotherapy

10.6

28.8

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

28.8

174

660

PJ5YQ, ,

NOMESCO Finland

+∞

28.7

1XC13, ,

NOMESCO Finland

+∞

28.7

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

28.7

A46

ICD-10 Finland

Erysipelas

1.5

28.7

1092

7403

SPAT1324

SPAT

Screening procedure

0.7

28.7

1007

13560

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

28.5

389

2037

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.1

28.5

120

375

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.7

28.5

234

HAB20

NOMESCO Finland

Excision of lactiferous duct

5.3

28.4

103

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

281.1

28.3

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

7.6

27.9

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

7.1

27.7

TPX15

NOMESCO Finland

Removal of vascular injection port

8.9

27.7

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

27.7

8500/2-C50.3

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast

+∞

27.7

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

+∞

27.7

8500/2-C50.2

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast

+∞

27.7

8401/3-C50.9

ICD-O-3

Apocrine adenocarcinoma of breast, NOS

+∞

27.7

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.0

27.7

191

A06AH03

ATC

naloxegol; oral

4.6

27.4

140

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

271.0

27.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

27.1

658

4046

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

5.7

27.0

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

27.0

457

2554

KCD02

NOMESCO Finland

Transurethral resection of bladder

6.1

27.0

6117B

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]

3.8

27.0

212

ZQZ00

NOMESCO Finland

Treatment of several skin areas

8.3

27.0

8575/3-C50.9

ICD-O-3

Metaplastic carcinoma, NOS, of breast, NOS

+∞

26.7

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

26.7

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

26.7

C49.39

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor

+∞

26.7

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

51.4

26.6

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

28.9

26.6

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

134.8

26.2

M05BX04

ATC

denosumab; parenteral

1.6

25.9

630

3873

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

32.8

25.9

M05BA02

ATC

clodronic acid; systemic

28.1

25.7

8523/3-C50.9

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of breast, NOS

+∞

25.6

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

25.6

C50.61

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, ductal tumor

+∞

25.6

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

25.6

8543/3-C50.9

ICD-O-3

Paget disease and intraductal carcinoma of breast of breast, NOS

+∞

25.6

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

25.6

C507, ,

ICD-10 Finland

+∞

25.6

N05CF01

ATC

zopiclone; oral

1.3

25.4

2908

23357

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

250.9

25.3

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.2

25.2

297

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

89.9

25.2

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

25.0

5736

59902

HA1AA, ,

SPAT

1.9

24.9

329

1705

Z2221

NOMESCO Finland

Medical doctor

1.3

24.9

2117

16346

HA5CB

NOMESCO Finland

Galactography

5.9

24.8

WX400

NOMESCO Finland

Inhalation anesthesy

1.9

24.8

300

1511

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

24.6

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

24.6

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

24.6

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

24.6

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

24.6

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

24.6

8522/3-C50.4

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast

+∞

24.6

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

24.6

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

4.9

24.3

107

ZX092, ,

NOMESCO Finland

240.9

24.3

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

23.7

704

4527

9729

FHL

Other measure in this category

5.3

23.6

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

23.6

PJ2D3

NOMESCO Finland

Histological assessment of lymph node

+∞

23.6

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

23.6

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

23.6

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

23.6

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

23.6

A21

ICPC

Risk factor for malignancy

28.0

23.5

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.7

23.5

823

11133

X77

ICPC

Malignant neopl genital female other

36.1

23.4

QBA10

NOMESCO Finland

Incision of skin of trunk

3.6

23.3

207

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.5

23.2

221

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.4

23.2

158

635

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

39.9

23.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

22.7

552

3392

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

9.6

22.7

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

6.0

22.7

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

22.6

871

5908

L01EF03

ATC

abemaciclib; oral

+∞

22.6

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

22.6

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

22.6

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

22.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

22.5

559

3452

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

62.5

22.4

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

22.3

212

979

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

22.3

152

611

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

221.3

22.3

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

221.3

22.3

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

21.8

259

HAD55

NOMESCO Finland

Incision of periprosthetic capsule of breast

33.7

21.6

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

21.5

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

21.5

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

21.5

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

21.5

8575/3-C50.4

ICD-O-3

Metaplastic carcinoma, NOS, of upper-outer quadrant of breast

+∞

21.5

9020/3-C50.9

ICD-O-3

Phyllodes tumor, malignant of breast, NOS

+∞

21.5

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

21.5

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

21.5

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.9

21.5

286

1488

JFB30

NOMESCO Finland

Right hemicolectomy

4.3

21.4

127

THA00

NOMESCO Finland

Needle biopsy of mamilla

7.5

21.4

HA1HA, ,

SPAT

7.2

21.3

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

211.7

21.2

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.6

20.8

118

435

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

20.8

293

1552

R84

ICPC

Malignant neoplasm bronchus/lung

48.1

20.7

2170A

ICD-9 Finland

Benign neoplasm of breast[NEOPLASMA BENIGNUM MAMMAE]

3.1

20.6

263

8520/3-C50.5

ICD-O-3

Lobular carcinoma, NOS, of lower-outer quadrant of breast

+∞

20.5

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

20.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

20.5

8480/3-C50.4

ICD-O-3

Mucinous adenocarcinoma of upper-outer quadrant of breast

+∞

20.5

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

20.5

L01CB01

ATC

etoposide; systemic

+∞

20.5

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

20.5

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

20.5

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

20.5

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.3

20.4

148

613

X18

ICPC

Breast pain female

2.2

20.3

175

778

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

202.0

20.2

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

202.0

20.2

ZXC96

NOMESCO Finland

Robot assisted procedure

3.4

20.2

199

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.2

19.7

236

HA1RA, ,

SPAT

1.5

19.6

542

3429

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

19.5

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

19.5

335

Kela drug reimbursment

Lapatinib

+∞

19.5

8504/2-C50.9

ICD-O-3

Encapsulated papillary carcinoma of breast, NOS

+∞

19.5

8401/3-C50.4

ICD-O-3

Apocrine adenocarcinoma of upper-outer quadrant of breast

+∞

19.5

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.6

19.4

116

439

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

19.4

475

2925

153

Kela drug reimbursment

Lenalidomid

192.4

19.2

HA1DM

NOMESCO Finland

Mammary gland very extensive MRI examination with 3 Tesla magnet

38.5

19.1

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.2

19.0

217

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

25.0

18.7

X79

ICPC

Benign neoplasm breast female

16.0

18.7

1511

Kela drug reimbursment

Olaparib

+∞

18.5

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

18.5

8530/3-C50.9

ICD-O-3

Inflammatory carcinoma of breast, NOS

+∞

18.5

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

18.5

389

Kela drug reimbursment

Olaparib

+∞

18.5

8523/3-C50.4

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast

+∞

18.5

8211/3-C50.2

ICD-O-3

Tubular adenocarcinoma of upper-inner quadrant of breast

+∞

18.5

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

67.2

18.4

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

26.7

18.3

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

96.2

18.2

QWF00

NOMESCO Finland

Reoperation for insufficiency of suture in plastic surgery of skin

96.2

18.2

HAF00

NOMESCO Finland

Excision of local recurrence of breast cancer

182.8

18.2

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

182.8

18.2

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.1

18.2

118

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

36.9

18.2

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.4

17.9

127

521

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

24.1

17.8

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

17.7

160

726

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

17.6

398

2403

L02AB02

ATC

medroxyprogesterone; systemic

3.6

17.5

152

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

17.4

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

17.4

L01AX03

ATC

temozolomide; systemic

+∞

17.4

8543/3-C50.1

ICD-O-3

Paget disease and intraductal carcinoma of breast of central portion of breast

+∞

17.4

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

17.4

8097/3-C44.3

ICD-O-3

Basal cell carcinoma, nodular of skin of other and unspecified parts of face

+∞

17.4

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

17.4

QCJ00

NOMESCO Finland

Liposuction in upper limb

21.9

17.3

HAB30

NOMESCO Finland

Excision of mamilla or areola

19.3

17.3

WPB10

NOMESCO Finland

Making a convalescent care decision

7.1

17.3

JAL00

NOMESCO Finland

Biopsy of peritoneum

4.9

17.3

ZXC90

NOMESCO Finland

Use of absorbable mesh in surgery

91.4

17.2

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

173.1

17.2

L04AX04

ATC

lenalidomide; oral

173.1

17.2

A08

ICPC

Swelling

1.5

17.1

514

3311

N02AA01

ATC

morphine; systemic, rectal

2.5

16.9

101

383

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.0

16.9

182

883

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.0

16.5

110

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

16.4

8500/2-C50.1

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast

+∞

16.4

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

+∞

16.4

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

16.4

9680/3-C50.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of breast, NOS

+∞

16.4

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

16.4

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

16.4

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

16.4

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

16.4

B01AB04

ATC

dalteparin; parenteral

1.6

16.4

354

2115

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

5.8

16.4

ZZS55

NOMESCO Finland

Distension of tissue expander

86.6

16.3

ZZS50

NOMESCO Finland

Insertion of tissue expander

86.6

16.3

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

86.6

16.3

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

163.5

16.2

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

163.5

16.2

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

163.5

16.2

C05.1

ICD-10 Finland

Malignant neoplasm: Soft palate

163.5

16.2

ZZA50

NOMESCO Finland

Full thickness skin graft

7.2

16.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

16.0

1707

13467

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

15.9

652

4467

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

15.8

354

2135

ZZR70

NOMESCO Finland

Perforator flaps

45.7

15.7

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.2

15.7

128

559

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

15.4

366

2237

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

15.4

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

15.4

8510/3-C50.4

ICD-O-3

Medullary carcinoma, NOS, of upper-outer quadrant of breast

+∞

15.4

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

15.4

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

15.4

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

15.4

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

15.4

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

15.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

81.8

15.3

L03AB05

ATC

interferon alfa-2b; parenteral

153.9

15.2

329

Kela drug reimbursment

Lenalidomide

153.9

15.2

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

153.9

15.2

103

Kela drug reimbursment

Diabetes, insulin-treated

0.8

15.2

1390

16371

SPAT1153

SPAT

Removal of sutures

1.2

15.0

2372

19520

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.2

15.0

119

514

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.8

14.9

261

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

43.3

14.8

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

14.6

371

2304

D75

ICPC

Malignant neoplasm colon/rectum

11.3

14.6

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.7

14.5

408

5785

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

54.5

14.5

E0000UV, ,

ATC

1.2

14.5

3531

30249

N60.1

ICD-10 Finland

Diffuse cystic mastopathy

2.5

14.5

343

WPA13

NOMESCO Finland

Palliative consultation

5.0

14.4

3090, ,

Kela drug reimbursment

15.8

14.4

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.8

14.4

1250

14826

8503/2-C50.4

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of upper-outer quadrant of breast

+∞

14.4

8500/2-C50.8

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast

+∞

14.4

1CD01, ,

NOMESCO Finland

+∞

14.4

1XC14, ,

NOMESCO Finland

+∞

14.4

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

14.4

L01XK01

ATC

olaparib; oral

+∞

14.4

8540/3-C50.0

ICD-O-3

Paget disease, mammary of nipple

+∞

14.4

8520/3-C50.8

ICD-O-3

Lobular carcinoma, NOS, of overlapping lesion of breast

+∞

14.4

C50.02

ICD-10 Finland

Malignant tumor of nipple and areola, lobular tumor

+∞

14.4

1744A, ,

ICD-10 Finland

+∞

14.4

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

14.4

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.4

14.3

385

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

77.0

14.3

A10BA02

ATC

metformin; oral

0.8

14.3

1529

17700

HAC99

NOMESCO Finland

Other mastectomy

144.2

14.2

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

10.4

14.1

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

16.3

13.9

GDC00

NOMESCO Finland

Lobectomy of lung

18.4

13.9

N05BA04

ATC

oxazepam; oral

1.2

13.9

2290

18900

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

10.9

13.9

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.7

13.8

256

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

6.1

13.8

T90

ICPC

Diabetes non-insulin dependent

0.8

13.7

1298

15249

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

1.9

13.7

166

841

GA5AA

NOMESCO Finland

Rib X-ray examination

4.7

13.7

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

5.0

13.5

-1, ,

ICD-10 Finland

1.6

13.4

296

1781

394

Kela drug reimbursment

Palbociclib

+∞

13.3

3030

Kela drug reimbursment

Abemaciclib

+∞

13.3

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

13.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

13.3

8522/3-C50.5

ICD-O-3

Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast

+∞

13.3

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

13.3

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

13.3

8520/3-C50.1

ICD-O-3

Lobular carcinoma, NOS, of central portion of breast

+∞

13.3

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

13.3

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

13.3

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

13.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

13.3

1501

Kela drug reimbursment

Palbociclib

+∞

13.3

C49.30

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax without histology

+∞

13.3

1515, ,

Kela drug reimbursment

+∞

13.3

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

72.2

13.3

XX2XW

NOMESCO Finland

Other teleradiological consultation

3.9

13.3

A26

ICPC

Fear of cancer, NOS

3.1

13.3

167

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

134.6

13.2

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

134.6

13.2

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

13.1

943

7062

ZXC82

NOMESCO Finland

Microsurgical

24.7

13.1

9722

FHL

Reduction plastic and possible mamilla transposition

3.7

13.0

103

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

12.9

120

553

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

12.8

1650

13261

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

12.8

4855

50189

JG1BG

NOMESCO Finland

MRI of rectum

11.6

12.7

E66.01

ICD-10 Finland

Obesity due to excess calories

0.7

12.7

378

5301

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

12.7

1242

9676

ZSP00

NOMESCO Finland

Procedure related to previous procedure classified in chapter P

27.2

12.7

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

48.1

12.6

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

67.2

12.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

12.3

1745

14157

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

12.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

12.3

Z44.3

ICD-10 Finland

Fitting and adjustment of external breast prosthesis

+∞

12.3

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

+∞

12.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

12.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

12.3

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

12.3

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

12.3

8509/2-C50.9

ICD-O-3

Solid papillary carcinoma in situ of breast, NOS

+∞

12.3

HA4RT

NOMESCO Finland

Breast seed implant placement under stereotactic guidance

+∞

12.3

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

12.3

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

12.3

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

12.3

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

12.3

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

12.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

12.3

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

12.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

12.3

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

12.3

C50.69

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, other or undeterminated histology

+∞

12.3

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

12.3

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

125.0

12.2

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

3.9

12.2

ZZA00

NOMESCO Finland

Split skin graft

2.0

12.2

135

663

HAD57

NOMESCO Finland

Resection of periprosthetic capsule of breast

16.6

12.2

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

19.2

12.2

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.0

12.0

172

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

12.0

300

1859

N60.0

ICD-10 Finland

Solitary cyst of breast

2.6

12.0

264

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

36.1

12.0

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

5.2

11.9

D77

ICPC

Malignant digestive neopl other/NOS

25.6

11.8

JAH00

NOMESCO Finland

Laparotomy

1.9

11.7

138

694

JFF10

NOMESCO Finland

Loop enterostomy

4.6

11.6

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.5

11.6

348

2244

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.6

11.6

257

WW200, ,

SPAT

0.8

11.6

2096

23099

WZC00, ,

SPAT

0.8

11.6

815

9953

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.1

11.6

112

525

R06AE07

ATC

cetirizine; oral

1.2

11.6

3862

33763

SPAT1152

SPAT

Removal of foreign body from under the skin

1.8

11.5

183

1009

A87

ICPC

Complication of medical treatment

2.8

11.5

203

C44

ICD-10 Finland

Other malignant neoplasms of skin

11.2

11.5

QBJ99

NOMESCO Finland

Other aesthetic correction of skin of trunk

14.1

11.5

WX707

NOMESCO Finland

Fiberoscopic intubation

5.3

11.4

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

28.8

11.4

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

62.4

11.4

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

+∞

11.3

C739, ,

ICD-10 Finland

+∞

11.3

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

11.3

C55

ICD-10 Finland

Malignant neoplasm of uterus, part unspecified

+∞

11.3

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

11.3

LE090

NOMESCO Finland

Profylactive radiotherapy of vulva and vagina

+∞

11.3

8097/3-C44.5

ICD-O-3

Basal cell carcinoma, nodular of skin of trunk

+∞

11.3

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

11.3

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

11.3

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

11.3

9120/3-C50.9

ICD-O-3

Hemangiosarcoma of breast, NOS

+∞

11.3

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

11.3

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

11.3

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

11.3

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

11.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

11.3

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

11.3

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

11.3

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

11.3

2499

21123

HAD35

NOMESCO Finland

Reduction mammoplasty with transplantation of areola

4.8

11.2

9710

FHL

Existence of a relapse

115.4

11.2

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

115.4

11.2

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

11.2

526

3693

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.2

11.1

134

ZX121

NOMESCO Finland

Central venous catheter

8.9

11.1

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

11.1

496

3454

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

11.0

834

6285

SAA01

NOMESCO Finland

Simple examination of mouth

0.9

11.0

5393

55020

JFF23

NOMESCO Finland

Transversostomy

3.8

11.0

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.8

10.9

1313

15069

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

10.1

10.9

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

10.7

227

1355

OAB42, ,

SPAT

0.8

10.6

633

7904

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.2

10.5

119

TJF80

NOMESCO Finland

Ostomy education

3.2

10.5

124

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

57.7

10.4

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.3

10.4

325

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

3.8

10.3

SAA02

NOMESCO Finland

Basic examination of mouth

0.9

10.3

4866

49904

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

+∞

10.3

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

10.3

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

+∞

10.3

C80.9

ICD-10 Finland

Malignant neoplasm, primary site unspecified

+∞

10.3

8520/3-C50.3

ICD-O-3

Lobular carcinoma, NOS, of lower-inner quadrant of breast

+∞

10.3

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

10.3

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

10.3

L01EH01

ATC

lapatinib; oral

+∞

10.3

1BC02, ,

NOMESCO Finland

+∞

10.3

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

10.3

8524/3-C50.9

ICD-O-3

Infiltrating lobular mixed with other types of carcinoma of breast, NOS

+∞

10.3

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

+∞

10.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

10.3

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

10.3

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

10.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

10.3

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

10.3

ZZQ60

NOMESCO Finland

Free microvascular graft of nerve

+∞

10.3

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

+∞

10.3

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

10.3

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

10.3

8522/3-C50.2

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast

+∞

10.3

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

105.7

10.2

9829

FHL

Other measure in this category

105.7

10.2

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

105.7

10.2

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

13.6

10.2

EBA00

NOMESCO Finland

Extraction of tooth

0.8

10.2

2102

22956

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

4.9

10.2

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.0

9.9

471

A14AB01

ATC

nandrolone; parenteral

4.3

9.8

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.7

9.8

182

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

9.8

105

512

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

38.4

9.8

ZXM40

NOMESCO Finland

Use of fluorescent substance

10.8

9.8

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

9.7

184

1067

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.4

9.7

268

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.3

9.7

304

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

16.0

9.6

ZXA10

NOMESCO Finland

Bilateral

1.2

9.6

1516

12404

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

25.0

9.6

L91.0

ICD-10 Finland

Hypertrophic scar

2.2

9.5

350

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

52.8

9.5

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

2.8

9.4

164

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.4

9.4

346

2326

ZXD05

NOMESCO Finland

Urgent procedure

1.2

9.4

1980

16617

Z2446

NOMESCO Finland

Social worker

1.4

9.4

340

2281

HA4GT

NOMESCO Finland

Labeling mammary gland pathology with galactographic guidance

3.7

9.3

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

9.3

292

1906

9705

FHL

Subcutaneous mastectomy

14.4

9.3

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

4.9

9.3

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

96.1

9.3

HA1DT

NOMESCO Finland

Mammary gland biopsy with MRI guidance

96.1

9.3

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

9.2

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

9.2

C51.81

ICD-10 Finland

Squamous cell carcinoma of the vulva

+∞

9.2

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

+∞

9.2

8503/3-C50.9

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of breast, NOS

+∞

9.2

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

+∞

9.2

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

9.2

8541/3-C50.9

ICD-O-3

Paget disease and infiltrating duct carcinoma of breast of breast, NOS

+∞

9.2

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

+∞

9.2

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

+∞

9.2

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

+∞

9.2

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

9.2

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

9.2

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

9.2

8520/2-C50.4

ICD-O-3

Lobular carcinoma in situ, NOS, of upper-outer quadrant of breast

+∞

9.2

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

9.2

8507/3-C50.9

ICD-O-3

Invasive micropapillary carcinoma of breast of breast, NOS

+∞

9.2

PJA13, ,

NOMESCO Finland

+∞

9.2

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

9.2

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

9.2

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

+∞

9.2

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

9.2

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

28.8

9.2

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

2.8

9.2

161

TQX05

NOMESCO Finland

Skin puncture, unspecified location

4.3

9.2

9734

FHL

Excision and local plastic or associated free skin grafting

2.8

9.2

156

JJB10

NOMESCO Finland

Atypcal resection of liver

20.8

9.1

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.7

9.1

176

1029

J05AB11

ATC

valaciclovir; oral

1.2

9.0

1177

9446

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

3.7

9.0

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

1.9

9.0

107

541

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

10.2

9.0

L02AE03

ATC

goserelin; implant

2.6

9.0

185

WZC30, ,

SPAT

0.7

8.9

431

5558

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.8

8.9

638

7783

G03FA01

ATC

norethisterone and estrogen; systemic

0.8

8.9

1280

14459

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

8.9

7835

72918

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

1.5

8.9

261

1681

E34.0

ICD-10 Finland

Carcinoid syndrome

35.3

8.8

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

11.0

8.8

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

15.0

8.8

ZXC50

NOMESCO Finland

Cryotherapy

1.7

8.8

152

863

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

17.9

8.7

PD2BD

NOMESCO Finland

Extensive CT angiography of pelvic organs

17.9

8.7

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

6.7

8.7

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

2.8

8.7

150

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

2.9

8.6

124

SFA10

NOMESCO Finland

One-surface restoration

0.9

8.6

3854

39898

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.7

8.6

349

4627

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

4.0

8.6

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.9

8.5

125

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.5

8.5

220

1378

HA1UA

NOMESCO Finland

Contrast-enhanced X-ray of the mammary gland

48.0

8.5

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

48.0

8.5

D76

ICPC

Malignant neoplasm pancreas

48.0

8.5

WE100

NOMESCO Finland

Profylactic cytostatic therapy

48.0

8.5

S04

ICPC

Lump/swelling localized

1.3

8.5

804

6233

SFA20

NOMESCO Finland

Two-surface restoration

0.9

8.4

4130

42520

KAC10

NOMESCO Finland

Total nephrectomy with capsule

7.3

8.4

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.3

8.3

251

L58.9

ICD-10 Finland

Radiodermatitis, unspecified

26.4

8.3

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

26.4

8.3

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

26.4

8.3

NK6SN

NOMESCO Finland

Bone SPECT

19.2

8.3

9844

FHL

Musculocutaneous tongue

86.5

8.3

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

86.5

8.3

HA1TA

NOMESCO Finland

Extensive combined assessment of mammary gland (mammography, ultrasound and sampling)

86.5

8.3

9822

FHL

Myocutaneous graft

86.5

8.3

PJW20

NOMESCO Finland

Lymphovenous shunt

86.5

8.3

189

Kela drug reimbursment

Imatinib

86.5

8.3

6101A

ICD-9 Finland

Benign mammary dysplasias, Diffuse cystic mastopathy

2.5

8.3

199

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

3.0

8.3

117

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

2.8

8.2

133

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

8.2

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

8.2

1XC07, ,

NOMESCO Finland

+∞

8.2

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

8.2

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

8.2

4CJ01, ,

NOMESCO Finland

+∞

8.2

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

8.2

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

+∞

8.2

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

+∞

8.2

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

8.2

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

8.2

8211/3-C50.5

ICD-O-3

Tubular adenocarcinoma of lower-outer quadrant of breast

+∞

8.2

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

8.2

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

8.2

9961/3-C42.1

ICD-O-3

Primary myelofibrosis of bone marrow

+∞

8.2

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

8.2

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

8.2

C49.19

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor

+∞

8.2

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

8.2

8480/3-C50.2

ICD-O-3

Mucinous adenocarcinoma of upper-inner quadrant of breast

+∞

8.2

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

+∞

8.2

L01BC59

ATC

trifluridine, combinations; systemic

+∞

8.2

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

8.2

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

8.2

1DB03, ,

NOMESCO Finland

+∞

8.2

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

8.2

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

8.2

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

8.2

1746A

ICD-9 Finland

Malignant neoplasm of female breast, Axillary tail

+∞

8.2

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

8.2

WC402

NOMESCO Finland

Demanding antibody therapy of local recurrence of tumour

+∞

8.2

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

+∞

8.2

L01XE01

ATC

[U] imatinib

+∞

8.2

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

8.2

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

8.2

8501/2-C50.9

ICD-O-3

Comedocarcinoma, noninfiltrating of breast, NOS

+∞

8.2

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.8

8.2

888

10325

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

8.2

1665

18259

XX9KE

NOMESCO Finland

Ultrasound examination with contrast

12.2

8.1

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

0.9

8.1

3137

32834

X20

ICPC

Nipple symptom/complaint female

3.0

8.1

113

WX002

NOMESCO Finland

Sedation and analgesia

1.2

8.1

1434

11844

A02BC05

ATC

esomeprazole; systemic

1.1

8.1

3545

31342

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.4

8.1

310

2104

ZX122

NOMESCO Finland

Intra-arterial

4.2

8.1

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

1.6

8.1

177

1068

K02.1

ICD-10 Finland

Caries of dentine

0.9

8.1

3977

40981

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

8.0

797

6209

ZXD20

NOMESCO Finland

Day surgery

1.2

8.0

953

7573

N02AX02

ATC

tramadol; systemic, rectal

1.1

8.0

3334

29369

H01CB02

ATC

octreotide; parenteral

9.0

8.0

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

8.0

968

7707

A10BK01

ATC

dapagliflozin; oral

0.7

8.0

288

3891

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

32.0

7.9

WPA15, ,

SPAT

16.5

7.9

HA1DG, ,

SPAT

21.1

7.8

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

3.8

7.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

7.8

4027

35954

S29

ICPC

Skin symptom/complaint other

1.2

7.8

1601

13393

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.2

7.8

290

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

2.9

7.8

111

A07AA09

ATC

vancomycin; oral

1.9

7.7

515

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.7

7.7

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

7.7

177

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

4.6

7.6

N81.1

ICD-10 Finland

Cystocele

0.8

7.6

563

6837

21899

ICD-8 Finland

Uterine fibroma

1.3

7.6

460

3366

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

3.4

7.6

HAA01

NOMESCO Finland

Suture of mammary gland

43.2

7.6

WPA42

NOMESCO Finland

Family-centered psychosocial intervention in palliative care

43.2

7.6

WE198

NOMESCO Finland

Palliative cystotatic therapy

43.2

7.6

J01FF01

ATC

clindamycin; systemic

1.2

7.6

1997

17032

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.8

7.5

117

645

SFA30

NOMESCO Finland

Three-surface restoration

0.9

7.5

2902

30421

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

7.5

642

4914

H01CB03

ATC

lanreotide; parenteral

14.4

7.5

G03DA02

ATC

medroxyprogesterone; systemic

1.2

7.5

1033

8331

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

7.5

1045

8441

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

1.9

7.5

432

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.8

7.5

114

626

XX9XW, ,

NOMESCO Finland

2.8

7.4

119

L03

ICPC

Low back symptom/complaint

0.9

7.4

2091

22397

L04AX03

ATC

methotrexate; systemic

0.8

7.4

534

6511

PJD99

NOMESCO Finland

Excision of other lymph nodes

24.0

7.4

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.2

7.4

277

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.4

7.4

198

L03.3

ICD-10 Finland

Cellulitis of trunk

2.3

7.4

228

G47.3

ICD-10 Finland

Sleep apnoea

0.8

7.4

1085

12243

A98

ICPC

Health maint/preventive medicine

0.8

7.3

8568

83613

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

7.3

1153

12934

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

1.9

7.3

449

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

77.0

7.3

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

77.0

7.3

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

77.0

7.3

B03XA02

ATC

darbepoetin alfa; parenteral

2.0

7.3

330

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.8

7.3

704

8288

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

7.2

1164

13034

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.2

7.2

C43

ICD-10 Finland

Malignant melanoma of skin

12.8

7.2

L88

ICPC

Rheumatoid/seropositive arthritis

0.7

7.2

206

2902

C54.12

ICD-10 Finland

Adenosquamous carcinoma of the endometrium

+∞

7.2

8480/3-C50.5

ICD-O-3

Mucinous adenocarcinoma of lower-outer quadrant of breast

+∞

7.2

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

+∞

7.2

C91.7

ICD-10 Finland

Other lymphoid leukaemia

+∞

7.2

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

7.2

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

7.2

8575/3-C50.5

ICD-O-3

Metaplastic carcinoma, NOS, of lower-outer quadrant of breast

+∞

7.2

369

Kela drug reimbursment

Regorafenib

+∞

7.2

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

7.2

8507/3-C50.4

ICD-O-3

Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast

+∞

7.2

8503/3-C50.4

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of upper-outer quadrant of breast

+∞

7.2

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

7.2

176

Kela drug reimbursment

Regorafenib

+∞

7.2

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

7.2

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

7.2

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

7.2

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

+∞

7.2

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

7.2

L01XX35

ATC

anagrelide; oral

+∞

7.2

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

+∞

7.2

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

7.2

9989/3-C42.1

ICD-O-3

Myelodysplastic syndrome, NOS, of bone marrow

+∞

7.2

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

+∞

7.2

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

7.2

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

7.2

8010/3-C50.4

ICD-O-3

Carcinoma, NOS, of upper-outer quadrant of breast

+∞

7.2

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

7.2

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

7.2

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

+∞

7.2

8480/3-C50.3

ICD-O-3

Mucinous adenocarcinoma of lower-inner quadrant of breast

+∞

7.2

8010/2-C50.9

ICD-O-3

Carcinoma in situ, NOS, of breast, NOS

+∞

7.2

8200/3-C50.9

ICD-O-3

Adenoid cystic carcinoma of breast, NOS

+∞

7.2

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

7.2

OAB47, ,

SPAT

0.7

7.2

200

2832

P20

ICPC

Memory disturbance

0.8

7.1

920

10517

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.3

7.1

504

3767

2506

FHL

Thyroidectomy

5.7

7.1

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.4

7.1

291

2002

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.6

7.1

137

803

A10AE04

ATC

insulin glargine; parenteral

0.7

7.1

332

4295

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.7

7.0

119

673

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

6.5

7.0

KMAK, ,

NOMESCO Finland

0.9

7.0

3437

35546

XX9CN, ,

NOMESCO Finland

28.8

7.0

A07AA02

ATC

nystatin; oral

1.3

7.0

467

3467

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

2.8

7.0

113

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.8

6.9

774

8975

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.2

6.9

229

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.7

6.9

238

3238

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.9

6.9

2412

25477

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.3

6.8

529

4004

C08CA01

ATC

amlodipine; oral

0.9

6.8

2776

29040

N81.6

ICD-10 Finland

Rectocele

0.8

6.8

562

6734

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

1.9

6.8

393

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.0

6.7

327

N05AX08

ATC

risperidone; systemic

0.8

6.7

407

5075

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

1.8

6.7

103

567

C03CA01

ATC

furosemide; systemic

1.1

6.7

2364

20549

M05BA04

ATC

alendronic acid; oral

1.2

6.7

920

7418

EB1VA, ,

NOMESCO Finland

0.8

6.7

1051

11796

C10AA07

ATC

rosuvastatin; oral

0.9

6.7

2503

26331

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.1

6.7

296

SPAT1193

SPAT

Pap smear

0.8

6.6

445

5474

C51.11

ICD-10 Finland

Squamous cell carcinoma of the labium minus

38.4

6.6

SPAT1310

SPAT

Counselling related to known health issue

0.9

6.6

2039

21729

SPAT1109

SPAT

Analgesia with portable analgesic pump

3.2

6.6

QX4YT

NOMESCO Finland

Puncture of superficial collection under ultrasound guidance

3.2

6.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.9

6.6

417

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

0.9

6.6

1854

19883

QC9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in upper extremities, unspecified

8.9

6.6

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

16.0

6.6

A10AC01

ATC

insulin (human); parenteral

0.7

6.6

237

3199

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

6.6

192

1240

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

6.5

516

6219

A02BA02

ATC

ranitidine; systemic

1.2

6.5

1533

12946

NBR30

NOMESCO Finland

Extensive or radical excision of soft tissue tumour of shoulder or upper arm

21.6

6.5

ZYC01, ,

SPAT

0.8

6.5

466

5677

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.4

6.4

304

2144

SPAT1262

SPAT

Handing over of treatment supplies

0.8

6.3

818

9352

21799

ICD-8 Finland

Benign neoplasm of breast

1.8

6.3

485

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.7

6.3

108

614

C49.20

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology

67.1

6.3

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

67.1

6.3

ZX004, ,

NOMESCO Finland

67.1

6.3

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

67.1

6.3

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

67.1

6.3

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

67.1

6.3

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

67.1

6.3

E66.8

ICD-10 Finland

Other obesity

0.7

6.3

211

2884

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

2.5

6.3

148

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

13.7

6.2

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.9

6.2

1628

17560

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.8

6.2

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.4

6.2

280

1962

ZXC15

NOMESCO Finland

Use of photodynamic technique

2.2

6.2

203

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

6.2

C574, 8461, 3

ICD-O-3

+∞

6.2

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

6.2

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

+∞

6.2

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

6.2

C49.29

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor

+∞

6.2

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

6.2

1512

Kela drug reimbursment

Ibrutinib

+∞

6.2

WB501

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of primary tumour

+∞

6.2

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

+∞

6.2

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

6.2

8503/2-C50.2

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of upper-inner quadrant of breast

+∞

6.2

8070/3-C51.9

ICD-O-3

Squamous cell carcinoma, NOS, of vulva, NOS

+∞

6.2

174

Kela drug reimbursment

Ruxolitinib

+∞

6.2

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

+∞

6.2

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

6.2

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

6.2

3065, ,

Kela drug reimbursment

+∞

6.2

9699/3-C50.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of breast, NOS

+∞

6.2

C16.33

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

+∞

6.2

C49.38

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the chest Ewing's sarcoma

+∞

6.2

C49.3

ICD-10 Finland

Malignant neoplasm: Connective and soft tissue of thorax

+∞

6.2

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

6.2

8071/3-C44.9

ICD-O-3

Squamous cell carcinoma, keratinizing, NOS, of skin, NOS

+∞

6.2

8480/3-C50.1

ICD-O-3

Mucinous adenocarcinoma of central portion of breast

+∞

6.2

17401

ICD-8 Finland

Malignant neoplasm of breast, Cutis

+∞

6.2

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

6.2

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

6.2

8041/3-C34.1

ICD-O-3

Small cell carcinoma, NOS, of upper lobe, lung

+∞

6.2

8523/3-C50.8

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of overlapping lesion of breast

+∞

6.2

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

+∞

6.2

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

6.2

C76.1

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Thorax

+∞

6.2

390

Kela drug reimbursment

Ibrutinib

+∞

6.2

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

6.2

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

6.2

8201/3-C50.9

ICD-O-3

Cribriform carcinoma, NOS, of breast, NOS

+∞

6.2

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

6.2

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

6.2

8201/3-C50.4

ICD-O-3

Cribriform carcinoma, NOS, of upper-outer quadrant of breast

+∞

6.2

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

6.2

L01EA01

ATC

imatinib; oral

+∞

6.2

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

6.2

20199

ICD-8 Finland

Hodgkin's disease

+∞

6.2

C84.43

ICD-10 Finland

Peripheral T-cell lymphoma, large cell type

+∞

6.2

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

6.2

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

6.2

18301

ICD-8 Finland

Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary

+∞

6.2

185

Kela drug reimbursment

docetaxel

+∞

6.2

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

+∞

6.2

WD435, ,

NOMESCO Finland

+∞

6.2

L01EF01

ATC

palbociclib; oral

+∞

6.2

L01EH03

ATC

tucatinib; oral

+∞

6.2

3009

Kela drug reimbursment

Niraparib

+∞

6.2

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

+∞

6.2

205

Kela drug reimbursment

Chronic hypertension

0.9

6.1

1594

17204

J05AB01

ATC

aciclovir; systemic

1.1

6.1

1801

15454

QBB10, ,

SPAT

1.8

6.1

498

HA1WT, ,

NOMESCO Finland

25.6

6.1

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

25.6

6.1

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

1.9

6.1

380

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

3.0

6.1

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

1.9

6.1

374

K86

ICPC

Hypertension uncomplicated

0.8

6.0

892

10072

SDA03

NOMESCO Finland

Periodontal treatment

0.9

6.0

2810

29222

N64.4

ICD-10 Finland

Mastodynia

1.4

6.0

284

2003

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

1.8

6.0

493

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

6.0

128

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768793) Breast Pathology biopsy report

2069

826

30.60

307.65

1.4

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1283

163

87.44

307.65

3.3

1.1

30.82

14.51

u/ml

5.53

1242

146

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5430

33496

2.33

307.65

2.7

2.4

—

estimate

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

247

34.77

307.65

1.2

1.1

—

(4035726) Immunohistochemistry procedure

2606

2206

15.34

307.65

1.5

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

738

77.62

307.65

3.3

1.1

34.05

22.99

u/ml

0.76

728

(40768795) Lymph node Pathology biopsy report

431

127

34.11

307.65

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

4105

22711

2.31

307.65

2.4

2.0

—

(3002256) Pathology report gross observation

2509

6684

4.56

307.65

1.4

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1888

4388

4.92

307.65

3.6

1.5

13.93

2.70

ug/l

4.86

1438

3274

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6269

39395

2.60

307.65

8.5

3.6

10.21

10.46

umol/l

0.90

6048

36739

(40768804) Tissue Pathology biopsy report

5014

29136

2.41

307.65

2.5

1.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

6330

42721

2.31

299.15

11.6

6.7

3.70

4.09

e9/l

43.06

5558

36217

(3015377) Calcium [Moles/volume] in Serum or Plasma

4760

29264

2.14

274.97

5.0

2.2

2.38

2.37

mmol/l

18.64

4420

25697

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7998

61231

2.77

264.08

10.8

5.8

80.96

76.42

u/l

12.13

7718

56918

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

627

1347

4.72

256.29

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3015

17099

2.02

199.42

2.3

2.0

—

(40758558) Short blood count panel - Blood

3655

23602

1.80

152.47

7.4

4.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1102

4643

2.45

148.55

3.5

1.5

92.24

24.06

u/ml

1.76

1074

4423

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1305

6069

2.24

139.55

1.8

2.0

0.22

0.21

g/l

6.61

1248

5542

(3023368) Bacteria identified in Blood by Culture

2887

18451

1.73

117.32

4.3

3.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5009

37641

1.60

103.00

5.8

5.1

1.22

mmol/l

0.68

4630

34063

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5494

42641

1.58

94.65

6.6

5.6

1.22

1.23

mmol/l

0.41

4641

36473

(3003694) ABO and Rh group [Type] in Blood

2776

18442

1.63

92.71

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4773

36183

1.54

88.81

4.4

3.6

35.54

36.11

g/l

10.12

4439

33242

(3033658) Prothrombin time (PT) actual/Normal

2704

18459

1.57

77.73

3.7

3.4

93.68

93.72

0.03

2655

17939

(3042936) Bacteria identified in Isolate by Culture

1575

9553

1.70

72.20

1.9

2.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1142

6453

1.80

66.81

4.5

2.2

254.79

235.71

u/l

3.66

1070

5959

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1805

11759

1.59

61.14

3.0

2.2

0.82

mmol/l

0.13

1691

10752

(3018418) pH of Serum or Plasma

3431

25864

1.43

56.10

4.1

3.3

7.40

0.24

2447

18277

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

409

1711

2.35

54.55

3.0

2.0

2476.02

34.70

u/ml

0.94

359

1380

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

8.09

52.89

6.3

1.5

29.53

84.30

ug/l

1.22

(4281824) Cell count and differential, peritoneal fluid

188

545

3.36

50.21

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1174

7504

1.57

41.65

3.3

3.2

—

(40768806) Pleura Pathology biopsy report

134

354

3.67

41.27

1.4

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1766

12424

1.45

39.32

1.9

1.8

—

(3032080) INR in Blood by Coagulation assay

4348

35498

1.33

38.19

13.2

14.1

1.21

1.23

inr

2.57

3589

29309

(40758358) Immune stain study

+∞

35.91

1.0

0.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

5445

46128

1.32

35.71

4.6

4.2

6.47

6.63

mmol/l

8.61

5199

43466

(3002030) Lymphocytes/Leukocytes in Blood

4499

37268

1.31

34.00

5.9

6.0

26.85

28.83

26.67

4246

34927

(3019069) Monocytes/Leukocytes in Blood

4418

36565

1.30

33.34

5.9

6.1

8.97

8.61

9.35

4124

33846

(3045142) Bone marrow Pathology biopsy report

106

284

3.61

32.06

1.3

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

161

562

2.78

31.34

1.3

1.4

32.62

28.94

g/l

3.23

148

487

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2365

18052

1.35

31.31

3.2

2.3

2.48

2.46

mmol/l

10.65

2142

15921

(3006504) Eosinophils/Leukocytes in Blood

4390

36510

1.29

31.03

5.9

6.0

2.64

2.91

12.27

4100

33761

(3018010) Neutrophils/Leukocytes in Blood

4398

36671

1.29

30.11

5.8

5.9

57.73

56.65

6.88

4178

34645

(3022096) Basophils/Leukocytes in Blood

4386

36586

1.28

29.81

6.0

6.1

0.69

0.71

2.17

4095

33793

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

318

1563

1.99

28.17

1.9

2.3

3.62

3.61

g/l

0.01

309

1468

(3012441) Differential panel - Pleural fluid

125

406

2.98

27.79

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1304

9261

1.41

26.49

1.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3150

25506

1.28

25.98

3.6

2.7

32.09

31.34

u/l

0.23

2969

23780

(3023199) Leukocytes [#/volume] in Pleural fluid

142

519

2.65

25.37

1.4

2933.35

2744.78

e6/l

0.06

361

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1229

8702

1.41

25.32

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

130

455

2.77

25.26

1.4

39457.64

48071.19

e6/l

0.13

243

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7602

76635

0.74

25.05

6.1

6.7

38.69

39.32

mmol/mol

11.60

6942

71268

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8035

80313

0.72

24.97

6.0

6.3

2.81

2.79

mmol/l

1.57

7283

74537

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

709

4521

1.55

24.86

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7890

79064

0.73

24.53

5.2

5.5

4.89

4.84

mmol/l

5.35

7171

73560

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

343

1812

1.85

24.48

1.6

1.9

96.39

96.88

0.15

337

1714

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

296

1506

1.92

23.74

1.5

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7840

78586

0.74

23.70

5.1

5.4

1.64

1.60

mmol/l

9.45

7079

72665

(3014111) Lactate [Moles/volume] in Serum or Plasma

894

6058

1.46

23.32

6.5

6.2

1.27

1.32

mmol/l

0.81

877

5928

(3012516) Albumin [Mass/volume] in Urine

2505

28621

0.78

23.21

3.1

3.3

32.21

31.27

mg/l

0.09

1281

16045

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

325

1719

1.84

23.12

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

329

1751

1.83

22.94

1.9

2.3

201.57

184.12

2.66

320

1629

(3020682) Albumin/Creatinine [Ratio] in Urine

2551

29031

0.78

22.73

3.7

3.9

6.84

6.58

mg/mmol

0.11

1278

16059

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

204

925

2.14

22.52

1.2

56.49

57.25

u/l

0.11

177

794

(3009508) Creatinine [Moles/volume] in Urine

2613

29594

0.79

22.20

3.1

3.3

6.07

6.25

mmol/l

1.72

2087

24761

(36304419) Bacteria [Presence] in Urine

2595

20834

1.27

22.08

3.1

3.0

3.89

130.72

estimate

0.61

118

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

858

5832

1.45

21.98

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

607

3843

1.55

21.94

8.1

8.0

24.60

24.64

mmol/l

0.11

593

3725

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7441

74981

0.77

21.60

4.3

4.5

1.24

1.26

mmol/l

2.89

6606

68472

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

220

1044

2.05

21.56

1.3

1.4

—

(3019225) pH of Specimen

1164

8390

1.38

21.33

4.3

3.7

7.37

7.36

0.90

826

5350

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

176

771

2.21

21.20

1.2

1.3

0.34

0.40

nmol/l

0.66

121

561

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

206

963

2.08

21.03

1.6

1.4

—

(3045788) Cell count panel - Pleural fluid

117

430

2.63

20.76

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

290

1538

1.84

20.49

1.5

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

138

554

2.41

20.37

1.8

1.2

—

(3003396) Base excess in Arterial blood by calculation

1085

7789

1.38

20.33

6.4

0.99

1.37

mmol/l

2.57

940

6439

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

117

442

2.56

19.66

1.2

1.3

—

(3019977) pH of Arterial blood

1090

7874

1.37

19.61

6.5

7.42

0.45

540

4473

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1588

12159

1.31

19.20

2.8

2.9

4.14

4.95

e6/l

1.26

722

5602

(3027801) Oxygen [Partial pressure] in Arterial blood

1086

7866

1.37

19.19

6.5

13.37

11.86

kpa

12.17

1051

7521

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1086

7868

1.37

19.16

6.5

5.15

5.09

kpa

1.42

1051

7526

(3014007) Fractional oxyhemoglobin in Arterial blood

640

4218

1.49

19.13

8.3

94.60

93.45

6.55

640

4204

(3030467) Casts [#/volume] in Urine by Automated count

2698

22046

1.25

19.13

3.1

0.40

0.43

e6/l

0.20

1894

15919

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

204

987

2.01

19.01

3.4

4.7

629.67

693.46

iu/ml

0.05

123

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

206

1004

1.99

18.81

3.3

2.1

272.42

22.20

u/ml

1.09

183

901

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

918

6491

1.40

18.77

3.7

2.9

1.24

mmol/l

0.35

804

5331

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1421

10752

1.32

18.69

1.9

1.8

29.10

29.20

0.21

1377

10403

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

265

1410

1.83

18.56

1.3

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

265

1410

1.83

18.56

1.3

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

619

4081

1.49

18.46

8.5

8.4

0.69

0.65

1.46

619

4060

(3021589) Normoblasts [#/volume] in Blood

4111

35220

1.22

18.22

12.3

9.9

0.00

e9/l

1.73

3257

28614

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

637

4238

1.48

18.15

8.3

8.2

1.25

1.36

2.76

637

4212

(3044889) 12 lead EKG panel

6348

56806

1.23

17.92

4.3

4.0

0.44

0.38

—

122

(3013115) Eosinophils [#/volume] in Blood

4797

41764

1.21

17.87

5.9

0.17

0.19

e9/l

20.89

4075

36202

(3000991) Gas panel - Venous blood

818

5729

1.41

17.65

7.7

7.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

349

2038

1.67

17.64

2.3

2.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

312

1771

1.72

17.53

2.6

3.2

0.37

0.38

iu/ml

0.27

172

1031

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

104

393

2.56

17.52

1.5

1.1

6.28

2.55

ug/l

0.36

307

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

351

2061

1.66

17.37

1.5

1.4

191.89

72.29

pmol/l

3.82

343

2014

(3019198) Lymphocytes [#/volume] in Blood

4732

41215

1.21

17.31

5.8

5.9

1.72

1.90

e9/l

12.90

4063

35998

(3001604) Monocytes [#/volume] in Blood

4641

40353

1.21

17.27

5.7

5.8

0.55

0.56

e9/l

0.87

3876

34406

(3006315) Basophils [#/volume] in Blood

4652

40496

1.20

16.97

5.7

5.8

0.04

e9/l

8.39

3889

34491

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

5.11

16.74

1.1

1.3

577.13

28.20

ug/l

0.57

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

276

2.83

16.70

1.2

10.60

10.86

u/l

0.06

237

(3007853) Bacteria identified in Skin by Aerobe culture

1177

8843

1.32

16.12

1.7

1.8

—

(3004809) Band form neutrophils/Leukocytes in Blood

171

827

2.00

16.02

3.1

2.2

1.56

1.11

0.98

154

719

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

155

727

2.06

15.80

1.9

2.2

488.33

1135.69

u/ml

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

8211

75951

1.31

15.78

19.5

13.4

78.68

77.12

ml/min/173m2

12.01

7804

69741

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

391

2.45

15.26

1.3

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

883

6414

1.36

15.18

7.2

7.1

117.46

119.69

g/l

3.19

870

6254

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

124

542

2.21

15.15

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

3025

25547

1.20

14.54

3.2

103.30

62.60

e6/l

0.61

2205

19131

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

122

539

2.19

14.54

1.3

1.2

21.28

21.65

u/l

0.02

450

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

197

1035

1.85

14.46

1.3

38.88

37.21

u/l

0.26

183

791

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

123

549

2.17

14.30

1.3

1.2

64.69

77.48

u/l

1.29

106

474

(3016502) Oxygen saturation in Arterial blood

932

6888

1.33

14.25

6.8

96.03

95.29

3.27

910

6628

(3036489) Thrombin time

395

2505

1.54

14.20

1.6

1.8

20.80

20.93

0.17

364

2159

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

370

2.43

14.14

5.6

1.2

61.27

265.29

u/ml

2.61

(3014576) Chloride [Moles/volume] in Serum or Plasma

1250

9635

1.28

14.00

6.4

5.8

103.86

103.78

mmol/l

0.21

1250

9630

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

150

731

1.99

13.82

1.3

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

154

3.25

13.70

2.5

2.3

1.39

0.89

0.92

154

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1398

10962

1.26

13.58

2.2

2.5

21.05

21.20

0.16

1271

9966

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

378

2424

1.52

12.93

1.8

1.21

2.22

ug/l

2.38

341

2074

(21494814) CD8 cells/Lymphocytes in Specimen

137

3.31

12.73

1.9

2.0

31.32

24.45

2.02

137

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8351

77759

1.29

12.65

18.8

14.0

22.97

21.04

mg/l

6.28

7035

62593

(3018095) Leukocytes [#/volume] in Urine

3465

29910

1.18

12.44

4.0

3.9

107.52

125.51

e6/l

0.75

2329

20167

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1718

13927

1.23

12.23

2.8

1.17

1.33

e6/l

1.05

857

7393

(40765096) Chromosome analysis panel by Banding

4.50

12.05

1.2

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1213

9478

1.26

12.04

4.4

1.04

mmol/l

0.13

1102

8526

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7896

78147

0.81

11.91

5.4

5.5

5.82

5.89

mmol/l

6.68

7104

71645

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

969

7395

1.29

11.64

2.2

39.07

39.84

u/l

0.05

814

6114

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

11.28

1.0

0.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

104

480

2.09

11.20

1.1

16.61

17.85

u/l

0.16

409

(3051651) Icteric interference index of Serum or Plasma

320

2.35

11.18

2.5

3.8

0.72

0.86

index

1.21

308

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

104

482

2.08

11.09

1.1

75.79

74.10

u/l

0.12

409

(3019150) Specific gravity of Urine by Refractometry

1879

20839

0.83

11.03

4.7

4.8

1.02

1.16

kg/l

0.81

1250

13592

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1488

12006

1.23

10.97

2.2

2.4

2.35

2.40

g/l

2.90

1346

10880

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

210

2.66

10.81

2.3

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

210

2.66

10.81

2.3

1.2

—

(1175426) CD3 cells/Lymphocytes in Blood

296

2.38

10.76

1.7

1.9

71.63

73.87

0.53

281

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1107

8668

1.26

10.74

2.2

2.0

7.44

6.11

umol/l

1.52

941

7323

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

388

2605

1.45

10.61

2.0

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

313

2.31

10.37

2.1

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

313

2.31

10.37

2.1

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

313

2.31

10.37

2.1

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

510

3614

1.38

10.25

8.0

8.2

15.56

15.79

1.32

496

3462

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

216

2.59

10.24

2.3

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

316

2.29

10.16

2.1

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

168

940

1.73

10.12

1.5

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

583

4231

1.34

10.06

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

413

2838

1.42

9.97

2.3

1.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1595

13103

1.20

9.69

2.2

2.5

12.25

12.67

umol/l

1.64

1466

11950

(3035880) pH of Pleural fluid

211

2.56

9.68

1.2

1.1

7.46

7.45

0.02

139

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

106

522

1.96

9.62

1.8

1.5

5.22

7.11

u/l

0.93

413

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1008

7907

1.25

9.59

2.7

1.8

393.25

373.57

nmol/l

2.35

943

7226

(3031040) Bacteria [#/volume] in Urine by Automated count

6079

55363

1.15

9.59

5.4

5.2

4891.51

3279.80

e6/l

0.57

699

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7851

77494

0.83

9.50

6.5

6.3

1.92

1.93

mu/l

0.27

7194

71890

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

166

2.73

9.24

1.8

2.5

43.88

48.47

1.00

102

(3027945) Reticulocytes/Erythrocytes in Blood

1014

7996

1.24

9.20

2.2

2.1

1.82

1.83

0.09

904

6945

(3011412) CD3 cells [#/volume] in Blood

402

2.06

9.05

2.4

2.1

1076.09

1224.51

e6/l

1.04

351

(21494434) Karyotype in Bone marrow

309

2.22

8.96

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4764

42773

1.14

8.90

2.5

81.82

2231.34

nmol/l

0.50

4244

38126

(3023487) Leukocytes [#/volume] in Peritoneal fluid

149

2.78

8.78

1.7

2.3

917.78

1220.76

e6/l

0.16

102

(44806118) Parainfluenza type 4 nucleic acid detection

137

755

1.75

8.77

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

137

755

1.75

8.77

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

137

755

1.75

8.77

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

137

755

1.75

8.77

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1019

8081

1.24

8.77

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

314

2114

1.44

8.54

2.9

3.1

3.68

1.39

index

4.86

144

960

(3024891) Influenza virus A+B Ag [Presence] in Specimen

267

1743

1.48

8.51

1.1

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

8623

81092

1.27

8.50

21.0

16.9

139.63

139.84

mmol/l

11.35

8461

79267

(40768443) Skin Pathology biopsy report

507

3703

1.33

8.42

1.3

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.21

8.38

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

107

559

1.85

8.20

1.8

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1605

17623

0.85

7.99

1.3

10.22

13.15

u/ml

1.05

570

6807

(3008757) Leukocyte morphology finding [Identifier] in Blood

103

539

1.84

7.87

3.1

2.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2101

17962

1.16

7.72

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

8626

81223

1.26

7.67

21.2

17.0

3.94

3.95

mmol/l

5.57

8453

79258

(3044007) Cell count panel - Peritoneal fluid

128

2.78

7.62

1.8

2.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

125

703

1.72

7.52

1.3

1.4

—

(3026782) Osmolality of Urine

1747

14757

1.17

7.49

2.7

2.9

482.10

488.94

mosm/kgh2o

0.72

1497

12709

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

112

613

1.76

7.41

1.8

1.2

—

(40768441) Liver Pathology biopsy report

370

1.95

6.90

1.2

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

798

6332

1.23

6.82

3.4

2.3

64.67

ml/min/173m2

0.00

347

2621

(3014891) Appearance of Pleural fluid

3.35

6.76

1.4

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

531

1.78

6.75

1.9

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

531

1.78

6.75

1.9

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

531

1.78

6.75

1.9

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1737

18743

0.86

6.75

1.3

1.4

34.44

37.20

iu/ml

0.31

534

6023

(3017354) Segmented neutrophils/Leukocytes in Blood

106

589

1.74

6.70

3.3

2.2

57.60

58.99

0.26

489

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

5.84

6.52

1.5

1.0

1.36

1.53

ug/l

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.91

6.51

1.2

1.7

35.57

21.75

g/l

4.52

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

216

1433

1.46

6.45

1.3

—

(3042631) Mycobacterium sp identified in Specimen

129

773

1.61

6.17

3.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

179

2.31

6.14

1.1

1.9

739.20

59481.11

u/ml

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6941

68682

0.88

6.08

5.2

5.1

14.96

14.88

pmol/l

1.71

6317

63175

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

186

1215

1.48

6.04

1.3

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

117

2.63

6.00

1.5

1.3

62.50

58.34

0.25

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2131

18518

1.14

5.99

1.7

1.27

1.08

mg/l

1.84

1689

14355

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

150

940

1.54

5.94

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

926

7559

1.20

5.92

3.0

3.2

82.05

82.10

ng/l

0.01

784

6349

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

113

2.64

5.86

3.2

1.2

66.96

75.81

ng/l

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

449

1.78

5.81

1.4

—

(3017181) Myelocytes/Leukocytes in Blood

826

6688

1.20

5.78

3.8

4.0

1.38

0.70

7.15

317

1293

(3017143) Hepatitis C virus Ab [Presence] in Serum

818

6618

1.20

5.77

1.4

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

522

1.72

5.74

2.4

2.6

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

6.94

5.73

3.2

1.2

—

estimate

—

(40761536) Microorganisms panel - Urine sediment

757

6095

1.21

5.62

4.4

4.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

133

2.46

5.59

1.9

4449.00

30454.33

e6/l

0.83

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

6.58

5.54

1.5

1.2

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6889

64077

1.12

5.53

24.0

17.0

13.81

13.59

34.35

6827

63068

(3035933) Granulocytes/Leukocytes in Blood

213

1458

1.41

5.44

2.7

3.0

58.51

57.69

0.37

213

1458

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

128

791

1.56

5.43

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

130

808

1.55

5.38

1.2

21.87

18.61

u/l

1.13

117

643

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

184

1229

1.45

5.38

1.3

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

2.71

5.37

1.5

1.2

1.59

3.10

0.57

(3022475) Manganese [Moles/volume] in Blood

3.75

5.35

1.1

0.17

0.16

umol/l

0.22

(3020630) Protein [Mass/volume] in Serum or Plasma

783

6362

1.20

5.29

2.6

1.5

65.38

66.62

g/l

4.06

707

5644

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

327

2408

1.31

5.26

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

106

1597

0.63

5.23

2.3

137.90

63.99

ug/min

0.84

850

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2951

26315

1.11

5.21

3.0

1258.46

1216.75

ng/l

0.24

2520

22417

(21494755) Public health laboratory ask at order entry panel

449

5347

0.80

5.18

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

684

5499

1.21

5.17

5.9

6.1

9.25

9.97

mmol/l

1.92

652

5212

(3022145) Colonoscopy Study observation

1098

9199

1.17

5.15

1.3

—

(3009343) pH of Capillary blood

552

4346

1.23

5.14

3.4

7.42

0.73

458

3589

(3023520) Reticulocytes [#/volume] in Blood

752

6130

1.19

4.91

2.3

2.1

69.74

70.57

e9/l

0.24

538

4538

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

9.61

4.89

1.2

1.0

—

(4034850) Laboratory test

222

2876

0.73

4.88

13.3

9.7

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.60

4.76

1.8

3.7

0.75

1.89

mg/l

—

(40767503) Oxygen content in Capillary blood by calculation

199

1384

1.39

4.69

2.5

2.6

16.07

16.33

0.60

191

1356

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3364

34296

0.91

4.60

4.4

3.01

0.78

estimate

0.95

722

6980

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

481

3780

1.23

4.59

3.3

3.2

2.23

2.15

mmol/l

0.20

373

2884

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2954

26490

1.10

4.54

2.8

2.3

272.58

59.64

u/l

0.50

2686

24120

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6509

64321

0.91

4.48

25.4

18.6

329.72

330.30

g/l

6.93

6472

63978

(3051611) Lipemic interference index of Serum or Plasma

120

766

1.51

4.47

2.8

3.3

13.77

13.40

index

0.13

308

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2008

20980

0.90

4.43

1.3

1.69

1.47

u/ml

0.23

457

5644

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

560

4488

1.21

4.42

3.4

5.21

5.24

kpa

0.38

533

4229

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1819

19104

0.89

4.40

1.7

66782956.14

35747122.51

pmol/l

0.88

1439

15663

(3028271) Lactate [Moles/volume] in Capillary blood

155

1050

1.42

4.29

1.7

1.8

1.72

1.66

mmol/l

0.25

146

1026

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.20

4.29

1.5

1.3

20.67

13.35

—

(3002179) Metamyelocytes/Leukocytes in Blood

776

6421

1.17

4.28

3.7

3.8

1.12

0.55

4.91

288

1275

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

423

1.66

4.12

1.8

1.7

—

(3022313) Gas panel - Capillary blood

391

3049

1.24

4.05

3.5

3.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

538

1.58

4.02

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

156

1074

1.40

3.97

1.5

1.3

—

(1761868) Lipid panel - Serum or Plasma

2846

29083

0.91

3.93

3.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

285

3457

0.78

3.93

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

332

2552

1.26

3.91

1.4

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

147

1007

1.41

3.86

1.6

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3674

37079

0.92

3.76

2.0

1.9

1.27

1.32

mmol/l

4.22

2940

30686

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

103

1448

0.68

3.75

1.3

1.8

0.84

0.81

nmol/l

0.17

1194

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5478

50791

1.09

3.69

3.3

3.1

47.52

40.29

u/l

5.70

5020

47063

(3024522) Salmonella sp identified in Specimen by Organism specific culture

155

1081

1.38

3.69

1.5

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

328

1.70

3.63

1.3

1.4

—

(3012501) Base excess in Blood by calculation

187

1347

1.34

3.63

3.1

3.4

2.74

mmol/l

0.00

148

949

(3019832) Treponema pallidum Ab [Presence] in Serum

323

3822

0.80

3.61

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

151

1054

1.38

3.58

1.3

—

(3021440) Promyelocytes/Leukocytes in Blood

777

6524

1.16

3.58

3.9

4.0

0.25

0.05

5.01

271

1131

(3000093) Morphology [Interpretation] in Blood Narrative

532

1.54

3.55

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

190

1.92

3.54

1.0

1.3

—

(3011544) Albumin [Mass/volume] in Pleural fluid

3.67

3.52

1.3

1.1

16.85

16.04

g/l

0.12

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

353

1.66

3.52

1.2

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

3.50

0.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

157

1108

1.37

3.49

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

145

1011

1.38

3.48

1.6

1.3

—

(3035715) Granulocytes [#/volume] in Blood

173

1244

1.34

3.42

2.8

3.1

4.33

3.97

e9/l

0.93

173

1244

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

156

1104

1.36

3.42

2.0

25.82

25.27

mg/l

0.05

358

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

154

1089

1.36

3.40

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

350

4078

0.82

3.39

1.3

2.23

0.71

u/ml

0.63

350

(3005988) Vibrio sp identified in Specimen by Organism specific culture

145

1016

1.38

3.39

1.6

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

335

1.67

3.38

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

335

1.67

3.38

1.4

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

247

2984

0.79

3.34

1.7

—

(3049717) Cytology report of Urine Cyto stain

239

1806

1.28

3.31

2.3

1.8

—

(3017732) Neutrophils [#/volume] in Blood

1205

10468

1.12

3.30

3.5

2.7

3.90

4.38

e9/l

4.76

1017

8834

(3023323) Follitropin [Units/volume] in Serum or Plasma

443

3582

1.20

3.26

1.4

1.3

45.68

35.66

iu/l

6.39

373

3169

(40761535) Cells panel - Urine sediment

604

6684

0.86

3.26

3.6

—

2.17

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2385

21461

1.09

3.22

2.3

2.5

2.89

2.83

mg/l

0.51

2004

18492

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

726

6122

1.15

3.18

3.1

4.39

4.43

pmol/l

0.49

656

5377

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

501

4107

1.18

3.17

3.4

24.34

24.58

mmol/l

0.88

490

4051

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

138

2.02

3.14

1.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

115

787

1.41

3.12

4.9

6.3

12.07

12.72

mg/l

0.91

104

718

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

4.55

3.11

1.0

352.00

102.23

u/l

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

307

2409

1.23

3.09

3.7

3.5

25.24

25.22

mmol/l

0.04

281

2158

(40760892) CBC W Ordered Manual Differential panel - Blood

1918

17132

1.09

3.05

4.4

4.2

—

(3008898) HLA-B27 [Presence]

236

2830

0.80

3.03

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

149

1072

1.34

2.99

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

110

1459

0.72

2.96

1.1

1.22

1.28

u/ml

0.04

755

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.29

2.96

2.1

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

312

1.63

2.92

1.3

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.31

2.86

1.2

0.45

1.71

mmol/l

0.89

(3000494) Fungus identified in Specimen by Culture

1133

9894

1.11

2.84

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1054

0.68

2.82

1.1

38.05

12615.62

iu/ml

0.55

189

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

144

1.94

2.82

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

144

1.94

2.82

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

2.57

2.82

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.57

2.82

1.3

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

6086

56946

1.07

2.78

5.1

2.01

140.88

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

647

7034

0.87

2.76

1.2

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.93

2.76

1.0

—

(3000850) Epithelial cells [#/volume] in Urine

1968

17670

1.09

2.76

2.7

2.6

7.89

7.50

e6/l

0.42

1771

15951

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

131

939

1.34

2.73

1.3

138.95

161.70

au/ml

1.31

277

(3028626) Oxygen [Partial pressure] in Capillary blood

200

1519

1.27

2.72

2.8

2.9

8.15

8.10

kpa

0.17

191

1481

(3021901) Oxygen saturation in Capillary blood

179

1345

1.28

2.67

2.9

89.91

90.18

0.20

170

1307

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

226

1750

1.25

2.62

2.3

2.6

1.47

1.61

mg/l

2.17

201

1536

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

501

1.46

2.58

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

527

5776

0.87

2.55

1.3

153.45

176.99

u/ml

0.44

485

5360

(3022689) Creatine [Moles/volume] in Urine

291

0.43

2.54

1.3

1.4

7.78

6.76

mmol/l

0.48

291

(3041918) Cholesterol [Moles/volume] in Pleural fluid

103

2.05

2.53

1.2

1.88

1.70

mmol/l

0.19

(3008536) Aspergillus sp Ab [Presence] in Serum

2.17

2.52

3.1

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

383

3137

1.18

2.51

1.7

1.6

1.61

1.65

g/l

0.32

320

2679

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

209

2478

0.81

2.49

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

380

1.52

2.49

2.1

2.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

237

1858

1.23

2.48

2.2

2.1

124.99

127.61

g/l

0.84

171

1415

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

506

1.45

2.47

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1800

16175

1.08

2.47

3.8

3.9

157.73

286.43

ng/l

2.69

1427

12404

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

656

0.63

2.45

1.3

1.2

278.00

210.83

titre

—

108

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

205

1585

1.25

2.44

1.5

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

2521

25477

0.93

2.42

4.6

0.00

estimate

0.44

875

8403

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

188

1.74

2.41

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

125

912

1.32

2.36

1.5

1.4

276.22

273.59

mosm/kgh2o

0.66

669

(3025159) Blasts/Leukocytes in Blood

766

6621

1.12

2.35

4.0

4.2

0.69

0.03

0.95

245

1093

(3024869) Neuronal Ab [Presence] in Serum

107

1.98

2.31

1.0

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

227

2641

0.82

2.28

1.4

1.5

8.50

8.56

iu/ml

0.00

502

(3005719) IgG [Mass/volume] in Serum or Plasma

663

5694

1.13

2.27

3.0

2.6

10.04

10.48

g/l

1.90

604

5226

(3012544) pH of Venous blood

862

7516

1.11

2.26

3.2

3.4

7.38

0.06

459

4196

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

954

0.71

2.17

1.2

1.3

7.35

7.52

mmol/l

0.18

814

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

421

4626

0.87

2.16

1.9

1.8

—

(3016879) Cocaine [Presence] in Urine

105

1326

0.76

2.14

2.3

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.98

2.13

1.7

2.3

4.20

5.18

ug/l

0.64

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

192

1500

1.23

2.13

1.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.12

2.07

3.0

1.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

109

798

1.31

2.05

1.8

1.6

32.59

31.79

1.06

109

790

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

290

0.50

2.04

8.0

11.7

831.53

5289.28

nmol/l

0.49

278

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

103

1290

0.76

2.00

1.3

1.5

1178.68

1038.77

mu/l

0.70

1004

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1222

10904

1.09

2.00

5.2

5.4

34.18

33.63

0.93

725

7034

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.79

1.97

1.1

1.4

—

(3037756) Immunofixation for Serum or Plasma

183

1438

1.23

1.95

1.4

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

308

1.50

1.94

1.1

1.5

32.10

30.63

umol/l

0.45

287

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8658

82448

1.11

1.93

15.7

10.9

24.38

23.31

u/l

2.75

8440

79396

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.20

1.88

1.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

286

2352

1.17

1.87

2.5

2.8

25.54

25.41

mmol/l

0.24

276

2313

(3002032) Base excess in Venous blood by calculation

824

7246

1.10

1.87

3.2

3.3

1.76

2.12

mmol/l

1.99

736

6486

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

672

7105

0.90

1.87

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

518

4445

1.13

1.85

2.0

1.6

1.30

1.28

g/l

0.10

470

4052

(3003888) Timothy IgE Ab [Units/volume] in Serum

1230

0.77

1.84

1.1

4.75

2.60

u/ml

0.42

580

(3037522) Nuclear Ab [Titer] in Serum

1274

13068

0.93

1.81

1.3

1.4

484.72

580.37

titre

1.34

305

3157

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.19

1.80

1.0

2.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1193

0.77

1.79

1.1

1.17

0.76

u/ml

0.34

474

(3040151) Glucose [Moles/volume] in Capillary blood

106

791

1.29

1.78

5.6

8.8

6.90

7.49

mmol/l

0.86

648

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

682

1.31

1.78

3.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

315

1.47

1.77

2.9

2.0

237.90

216.77

e6/l

0.28

269

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

469

4019

1.13

1.74

1.3

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

216

1.56

1.71

2.7

2.0

165.91

161.02

0.12

200

(4024509) Urine culture

456

4897

0.89

1.70

2.1

2.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8739

83312

1.11

1.70

25.6

18.4

69.87

70.75

umol/l

2.99

8637

82100

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

439

0.63

1.69

1.2

1.5

79.86

57.23

ug/l

1.35

439

(1001926) Buprenorphine [Presence] in Urine by Screen method

1117

0.77

1.69

2.4

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.12

1.67

1.7

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

380

4120

0.88

1.67

1.8

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1082

0.77

1.66

4.1

5.2

376.35

366.29

umol/l

0.29

938

(3013005) Retinol [Moles/volume] in Serum or Plasma

312

1.45

1.65

1.1

1.5

2.00

umol/l

0.01

280

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

312

1.45

1.65

2.9

2.0

524.22

439.18

e6/l

0.73

251

(3004775) Volume in Urine collected for unspecified duration

528

0.67

1.65

2.1

2.3

595.19

626.09

0.17

380

(3027923) C peptide [Moles/volume] in Serum or Plasma

435

0.64

1.64

1.6

1.5

1.23

1.29

nmol/l

0.10

326

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

130

1533

0.81

1.59

1.2

1.3

145.45

302.81

titre

2.15

151

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

373

0.62

1.59

1.0

1.1

1952.21

1573.97

miu/ml

0.72

373

(3048689) Calprotectin [Mass/mass] in Stool

1139

11666

0.93

1.58

2.1

131.31

120.57

ug/g

0.21

885

9046

(3028707) Methadone [Presence] in Urine by Screen method

657

0.71

1.57

3.6

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

995

8901

1.08

1.57

1.6

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

766

0.74

1.55

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

249

2761

0.86

1.54

1.4

1.7

0.24

0.23

g/l

0.22

236

2620

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

646

6764

0.91

1.52

2.2

2.4

5.00

5.87

ug/l

0.88

528

5761

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

350

1.40

1.52

1.1

73.17

84.52

—

(3007916) DNA double strand Ab [Titer] in Serum

136

0.42

1.52

1.2

1.3

—

214.19

—

(3028300) Cannabinoids [Presence] in Urine

123

1448

0.81

1.50

2.1

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

839

7471

1.09

1.49

3.2

3.3

5.77

5.86

kpa

1.81

817

7289

(1002224) Polysomnography panel

299

3264

0.88

1.49

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

385

4136

0.89

1.48

1.5

1.8

5.63

7.41

iu/ml

0.64

997

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.95

1.48

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

693

0.73

1.47

1.0

48.88

47.98

ng/l

0.05

468

(3011288) Drugs identified in Urine by Screen method Nominal

997

0.78

1.46

1.8

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

122

1433

0.81

1.46

2.1

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

136

1580

0.82

1.46

1.4

—

(44813793) Dust mix specific IgE antibody measurement

680

0.73

1.45

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

398

0.65

1.44

1.1

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

274

3000

0.87

1.44

1.3

2.70

4.60

u/ml

0.57

300

(3027008) Opiates [Presence] in Urine

123

1440

0.82

1.44

2.1

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.49

1.43

1.1

1.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.74

1.43

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

256

2815

0.87

1.43

1.4

1.7

1.18

1.21

g/l

0.94

245

2671

(3006270) Folate [Moles/volume] in Blood

706

1.27

1.43

1.2

332.29

364.61

nmol/l

0.80

588

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

298

3242

0.88

1.42

1.3

51.48

47.61

u/ml

0.06

185

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

135

1.64

1.41

1.6

1.4

72.03

71.52

0.06

130

(1616796) Gas panel - Central venous blood

173

1404

1.19

1.41

3.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

542

0.71

1.39

1.4

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

968

0.78

1.39

1.0

1.1

4.86

2.72

u/ml

0.67

441

(3000012) Reticulocyte production index

112

872

1.24

1.39

1.8

1.7

0.83

0.88

0.60

522

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

335

3611

0.89

1.39

1.6

16.56

18.40

u/ml

0.17

729

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

685

0.74

1.38

1.0

974.17

371.11

ng/l

0.48

470

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1062

0.79

1.37

1.1

0.93

0.97

u/ml

0.03

499

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

650

0.74

1.36

1.2

1.5

—

(3047189) Immunofixation for 24 hour Urine

198

1.50

1.36

1.5

1.2

—

(3019060) Gas panel - Arterial blood

482

4206

1.11

1.35

3.7

4.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

218

2412

0.86

1.34

1.3

1.5

0.33

0.30

mg/l

0.31

954

(3024980) IgG subclass 4 [Mass/volume] in Serum

118

1376

0.82

1.34

1.4

1.5

0.62

0.68

g/l

0.42

1068

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

275

2994

0.88

1.34

1.3

10.32

7.11

u/ml

0.33

487

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.76

1.34

1.1

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

756

1.25

1.33

1.3

1.2

112.90

110.78

pmol/l

0.16

756

(3023183) Ammonium ion [Moles/volume] in Plasma

154

1246

1.19

1.31

2.6

2.4

35.62

31.63

umol/l

1.27

132

1111

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

689

0.75

1.31

1.0

739.05

719.19

ng/l

0.12

452

(3027944) Amphetamines [Presence] in Urine

123

1421

0.83

1.29

2.2

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

504

1.30

1.28

2.0

1.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.33

1.28

1.1

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

480

1.30

1.26

2.3

18.59

23.07

iu/ml

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

922

0.79

1.26

1.0

1.1

3.07

3.12

u/ml

0.01

373

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

347

1.36

1.26

1.8

1.6

0.42

0.36

ug/l

0.44

230

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.40

1.24

9.3

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

279

0.62

1.23

1.3

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

832

0.78

1.22

2.0

1.5

38.85

32.81

0.61

470

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.73

1.21

1.1

1.2

22.70

78.54

ng/l

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

500

4403

1.10

1.19

5.7

6.1

25.11

24.82

mmol/l

1.07

482

4214

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.68

1.18

1.1

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

305

2620

1.12

1.18

1.8

2.1

308.05

584.73

ug/l

1.96

276

2461

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

356

0.67

1.18

1.3

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

179

0.54

1.17

1.4

1.5

—

(3003181) Sodium [Moles/volume] in Urine

223

1879

1.14

1.17

1.4

66.02

60.03

mmol/l

1.16

180

1505

(3001019) Free T4 and TSH panel - Serum or Plasma

370

3914

0.90

1.14

1.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.69

1.13

1.1

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

107

0.45

1.13

1.2

1.1

1.95

1.58

umol/24h

—

107

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.72

1.12

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

713

1.23

1.12

2.0

1.8

0.54

0.98

g/24h

2.36

355

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.32

1.12

1.1

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

222

2414

0.88

1.11

1.2

1.3

47.02

50.29

u/ml

0.09

250

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

271

0.64

1.11

1.9

1.7

10.19

9.05

ug/l

0.48

271

(3039162) Centromere protein B Ab [Units/volume] in Serum

118

1345

0.84

1.10

1.3

98.96

62.84

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

127

1030

1.19

1.10

1.1

1.2

278.45

285.44

u/ml

0.10

635

(3025130) Human papilloma virus identified in Specimen

187

1565

1.15

1.10

1.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.24

1.09

1.1

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.70

1.08

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.70

1.08

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

174

0.55

1.08

1.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

771

0.80

1.05

1.4

1.5

65.51

58.53

ug/l

0.47

602

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

142

0.54

1.03

3.1

2.0

14.34

17.93

umol/l

—

142

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

102

0.47

1.01

1.0

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

133

1.52

1.00

1.6

1.4

348.10

527.83

mu/l

1.50

128

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.82

1.00

3.4

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

464

1.26

1.00

1.1

21.32

16.73

u/ml

0.28

175

(3034092) Cytoplasmic Ig cells/cells in Blood

106

0.45

1.00

13.8

9.2

0.16

0.21

—

106

(3020911) Cortisol [Moles/time] in 24 hour Urine

313

1.32

0.98

1.3

67.11

67.55

nmol/24h

0.02

313

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

111

1254

0.85

0.97

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

365

1.29

0.95

2.0

8.71

8.22

mmol/l

0.19

365

(37208534) Antinuclear antibody arbitrary concentration in serum

298

1.32

0.95

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

104

1.57

0.94

1.4

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

187

1586

1.13

0.94

1.1

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

238

2544

0.90

0.94

1.3

1.46

6.42

u/ml

1.89

168

(3014051) Protein [Presence] in Urine by Test strip

2597

24244

1.04

0.94

3.3

0.09

0.06

0.38

752

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

169

1844

0.88

0.94

1.2

1.1

0.57

0.59

ratio

0.23

292

(3003740) Influenza virus B Ag [Presence] in Specimen

129

1066

1.16

0.93

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

403

4194

0.92

1.1

489.60

172.77

titre

—

(3022621) pH of Urine by Test strip

736

7490

0.94

0.92

3.2

2.9

6.16

6.09

1.25

476

5046

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.87

0.92

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

830

0.82

0.91

1.0

0.56

0.24

u/ml

0.35

251

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.13

0.91

3.7

3.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

193

1.39

0.90

1.0

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

166

1402

1.14

0.90

1.2

0.15

0.24

nmol/l

1.44

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

733

1.19

0.90

2.0

2.2

2.26

5.81

u/field

0.51

374

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3403

31951

1.04

0.90

4.0

3.8

30.48

60.73

ng/l

2.16

2436

21628

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

420

1.26

0.90

1.8

2.0

0.92

2.26

u/field

2.14

266

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

605

0.79

0.89

1.7

363.16

377.39

mu/l

0.15

476

(3001729) Color of Synovial fluid

1.70

0.88

2.6

1.8

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

232

0.66

0.87

1.3

1.1

0.69

0.65

umol/24h

—

105

(4212803) Bone marrow aspirate examination

1.87

0.87

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

614

0.80

0.87

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

142

1190

1.15

0.87

1.2

0.19

0.18

nmol/l

0.07

114

917

(3025941) Bacteria identified in Stool by Culture

497

4449

1.08

0.87

1.2

1.3

—

(3024928) Oxygen saturation in Venous blood

212

1824

1.12

0.86

2.1

2.8

61.31

60.17

0.31

203

1764

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.99

0.86

1.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2816

27706

0.97

0.86

2.1

144.27

177.26

u/l

2.68

2651

25920

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

227

2416

0.90

0.85

1.7

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

128

1067

1.15

0.85

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

863

0.83

0.84

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

8762

84457

0.94

0.84

29.9

21.7

129.67

132.43

g/l

82.74

8666

83338

(3010813) Leukocytes [#/volume] in Blood

8762

84456

0.94

0.83

29.7

21.6

6.37

6.53

e9/l

8.13

8568

81976

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.58

0.82

1.1

1.0

0.02

0.05

u/ml

0.82

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.75

0.82

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

608

0.80

0.81

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

8762

84448

0.94

0.81

29.7

21.6

4.32

4.41

e12/l

66.25

8566

81976

(3010937) Rubella virus Ab [Presence] in Serum

1.86

0.81

1.0

1.1

—

(3016750) Collection duration of Urine

382

0.75

0.80

2.1

2.2

486.95

504.76

min

0.49

302

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

8762

84447

0.94

0.80

30.1

21.9

39.54

40.07

0.57

8663

83282

(3034891) Synovial lining cells/cells in Synovial fluid

468

0.78

0.80

1.6

1.5

3.70

4.46

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

117

1.48

0.79

1.0

92.99

79.97

ug/l

1.06

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

779

1.17

0.79

1.1

98.15

95.32

0.47

725

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.79

0.0

2.8

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.78

0.0

1.0

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

8762

84441

0.94

0.78

29.6

21.5

91.75

91.22

25.73

8662

83307

(3030981) Hyaline casts [#/volume] in Urine by Automated count

637

6469

0.94

0.78

2.2

0.50

0.44

e6/l

0.30

614

6103

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.80

0.78

1.2

1.1

0.03

u/ml

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

670

6792

0.94

0.77

1.6

1.36

1.39

0.71

568

5898

(3035941) MCH [Entitic mass]

8762

84439

0.94

0.77

29.6

21.5

30.31

30.19

8.68

8662

83305

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

122

1023

1.15

0.77

1.1

124.34

123.91

0.04

110

908

(3004616) Nuclear Ab [Presence] in Serum

119

1306

0.87

0.76

1.4

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

728

0.83

0.76

1.6

1.4

—

3.00

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

190

2024

0.90

0.75

1.2

1.67

1.62

g/l

1.85

190

2024

(3038177) Helicobacter pylori Ab [Presence] in Serum

127

1386

0.88

0.75

1.2

—

(3003129) Base excess in Capillary blood by calculation

819

1.16

0.75

2.0

2.1

1.57

1.20

mmol/l

0.49

794

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

189

0.66

0.74

1.1

1.5

—

(40762365) Oxygen content in Arterial blood by calculation

1.60

0.74

1.4

2.1

14.29

15.00

ml/dl

0.52

(3044927) Protein electrophoresis panel - Urine

850

0.85

0.74

1.1

1.2

—

(3007461) Platelets [#/volume] in Blood

8762

84427

0.94

0.73

29.7

21.6

258.63

261.26

e9/l

3.38

8580

82344

(3035350) Ketones [Presence] in Urine by Test strip

4702

45790

0.97

0.73

4.4

2.81

3.28

estimate

0.08

961

9261

(3001964) Herpes simplex virus Ag [Presence] in Specimen

178

1.35

0.70

1.1

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

824

0.85

0.69

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

286

2972

0.92

0.69

1.2

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

338

0.77

0.67

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.55

0.67

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

180

1.33

0.66

1.9

2.4

0.61

mmol/l

0.01

180

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

294

0.75

0.66

1.2

0.30

0.31

g/l

0.31

242

(3035320) C reactive protein [Mass/volume] in Body fluid

651

1.17

0.66

2.2

2.8

31.03

25.95

mg/l

0.46

456

(3026726) Creatinine [Moles/volume] in Specimen

1.78

0.66

1.2

3.9

43.20

385.67

umol/l

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

715

0.84

0.65

1.4

1.25

1.16

ratio

0.41

415

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

715

0.84

0.65

1.4

1.22

1.14

ratio

0.25

412

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

715

0.84

0.65

1.4

1.00

0.97

ratio

0.22

412

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

432

0.80

0.65

1.1

1.2

1.03

1.06

ratio

1.12

350

(21494890) Protein electrophoresis panel - 24 hour Urine

599

1.17

0.64

1.6

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

467

1.19

0.63

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

159

0.66

0.63

3.7

5.6

9.38

8.08

mmol/l

0.88

159

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

216

1.29

0.62

2.4

3.0

10.57

10.55

kpa

0.01

216

(3021960) Folate [Moles/volume] in Serum or Plasma

2745

25827

1.03

0.62

1.7

21.35

21.55

nmol/l

0.29

2241

21377

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

710

0.85

0.61

1.3

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

257

0.75

0.61

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

257

0.75

0.61

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

257

0.75

0.61

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

257

0.75

0.61

1.1

—

(3017704) Immunofixation for Urine

375

0.79

0.61

1.5

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

719

0.85

0.60

2.3

2.9

24.68

37.98

mg/l

0.40

476

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

312

1.23

0.60

1.2

11.70

11.61

mm/h

0.02

312

(3024263) Appearance of Synovial fluid

417

1.20

0.60

1.8

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.60

0.0

9.6

—

56.21

—

(3020650) Glucose [Presence] in Urine

267

0.75

0.60

1.8

0.00

0.02

estimate

0.80

267

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

1.4

—

112.40

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.59

0.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

278

1.24

0.59

1.2

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

278

1.24

0.59

1.2

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

220

1945

1.09

0.59

3.9

4.1

3.82

3.81

mmol/l

0.14

220

1932

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.75

0.58

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

128

1366

0.90

0.57

1.6

14.04

19.64

u/ml

—

(40757373) Influenza virus identified in Isolate

118

1.38

0.57

1.2

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

446

1.18

0.57

1.4

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

700

6437

1.05

0.57

2.7

2.9

4.49

4.40

kpa

0.63

681

6277

(3027456) Digoxin [Moles/volume] in Serum or Plasma

230

2042

1.08

0.57

3.4

3.6

0.84

0.82

nmol/l

0.20

186

1693

(3027135) IgG subclass 1 [Mass/volume] in Serum

858

0.87

0.57

1.3

1.5

6.58

6.64

g/l

0.04

627

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

601

0.85

0.57

1.4

1.3

—

352.00

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

616

1.15

0.57

1.1

1.4

2.47

2.18

mmol/l

0.59

568

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

527

1.17

0.56

1.0

—

(3004451) EKG impression Narrative

447

1.18

0.56

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

857

0.87

0.56

1.3

1.5

0.45

0.39

g/l

0.37

627

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.65

0.56

1.0

0.08

0.39

u/ml

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

109

933

1.12

0.56

1.2

31.39

21.20

u/l

1.04

807

(3028192) IgG subclass 2 [Mass/volume] in Serum

856

0.87

0.55

1.3

1.5

2.71

2.89

g/l

0.52

624

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

306

0.78

0.55

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

413

1.19

0.55

1.4

1.7

4.01

3.82

nmol/l

0.04

333

(3037121) Protein [Mass/volume] in Urine

276

2473

1.07

0.55

3.1

2.5

437.15

392.79

mg/l

0.06

683

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

817

1.13

0.54

1.6

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

219

0.74

0.54

1.0

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

103

1.40

0.54

1.1

1.7

1733339.70

359265.25

nmol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

204

1.27

0.54

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

441

0.83

0.53

1.0

0.35

1.18

u/ml

0.73

143

(3034274) Bile acid [Moles/volume] in Serum --fasting

648

0.86

0.53

1.4

1.7

5.81

6.99

umol/l

0.49

469

(3020191) Ethanol [Moles/volume] in Serum or Plasma

472

0.83

0.53

1.2

1.5

1.08

1.04

promille

0.07

353

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

142

1498

0.91

0.53

1.2

8.75

13.95

u/ml

—

(3036603) Volume of Urine

549

1.16

0.52

1.4

1765.41

1882.42

0.53

528

(3012494) Peanut IgE Ab [Units/volume] in Serum

217

0.75

0.51

1.0

0.28

0.99

u/ml

—

109

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

217

0.75

0.51

1.0

4.64

9.54

u/ml

—

126

(3050794) Legionella sp Ab [Presence] in Serum

1.42

0.51

1.0

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

514

1.16

0.51

1.2

1.3

35.54

23.42

umol/l

1.68

468

(4062490) Immunoglobulin typing, IgG

840

0.88

0.51

1.3

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

146

1.32

0.51

1.3

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

341

3087

1.06

0.51

3.8

4.3

0.89

0.87

0.21

326

2918

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

454

4581

0.95

0.51

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

155

1.30

0.50

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

217

1935

1.08

0.50

1.8

1.9

5.51

4.96

mmol/24h

1.56

186

1701

(3004716) Salmonella sp identified in Stool by Organism specific culture

380

3850

0.95

0.50

1.3

1.4

—

(4198724) Urine methamphetamine measurement

161

0.72

0.49

1.0

1.3

—

(3045414) Leukocytes [Presence] in Urine

929

9217

0.96

0.49

2.2

2.1

0.03

0.01

estimate

0.31

122

1764

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

185

1920

0.92

0.49

1.3

228.37

223.07

miu/ml

0.06

918

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

216

1.25

0.49

2.4

3.0

5.01

5.19

kpa

0.38

216

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

621

5723

1.04

0.48

1.3

70.44

53.42

au/ml

1.16

360

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

149

0.71

0.48

1.5

1.7

1.24

1.19

mmol/l

1.25

144

(3043238) Trisomy 21 risk [Likelihood] in Fetus

641

0.87

0.48

1.3

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.49

0.47

1.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

367

1.18

0.47

1.6

1.9

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.46

0.47

1.1

1.0

0.01

0.37

u/ml

—

(3007566) Smooth muscle Ab [Titer] in Serum

258

2326

1.07

0.46

1.2

162.17

149.46

titre

0.07

203

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.43

0.46

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.62

0.46

1.4

1.1

5.62

6.10

mmol/l

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

391

0.83

0.45

1.0

1.1

1.34

1.13

u/l

0.51

172

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.59

0.45

2.0

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

678

0.88

0.45

1.0

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

259

2338

1.07

0.45

2.0

1.5

0.03

0.00

g/l

0.97

225

2099

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

369

1.17

0.44

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2413

23564

0.98

0.44

3.8

3.7

1.17

0.37

estimate

0.74

742

7031

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.36

0.44

1.0

1.1

9.00

8.53

u/ml

0.04

(40768797) Stomach Pathology biopsy report

1342

12577

1.03

0.43

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

344

1.17

0.43

1.4

0.93

1.30

nmol/l

1.28

285

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

593

0.87

0.42

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.41

0.42

1.0

—

(3017569) Oxygen content in Arterial blood

398

1.16

0.42

2.3

2.0

16.08

15.78

0.37

398

(3047352) Trisomy 18 risk [Likelihood] in Fetus

613

0.88

0.42

1.4

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

212

1.22

0.42

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

765

0.89

0.42

1.0

1.1

—

72.11

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

344

3472

0.95

0.42

1.4

1.6

8.62

16.95

iu/ml

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

265

1.20

0.42

2.6

2.1

49.64

53.20

umol/l

0.28

214

(3021601) Nitrite [Presence] in Urine by Test strip

4658

45145

0.98

0.41

4.3

4.4

0.00

estimate

0.53

922

8833

(3034614) HLA Ag [Interpretation]

0.00

0.41

0.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

3509.47

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.41

0.0

1.0

—

0.17

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.06

—

(3009261) Glucose [Presence] in Urine by Test strip

4761

46130

0.98

0.41

4.4

1.07

0.14

estimate

0.41

938

8844

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

1.39

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.03

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

5.9

—

334.53

—

(44806420) Estimation of glomerular filtration rate

110

966

1.09

0.40

2.2

2.7

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.39

0.0

3.5

—

2.29

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

692

1.11

0.39

1.5

1.3

41.25

60.00

titre

—

(3005033) Fetal Nuchal fold Thickness US

608

0.88

0.38

1.3

1.4

1.28

0.00

402

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1066

10492

0.97

0.38

7.1

6.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

703

1.11

0.37

1.5

1.3

128.33

677.36

titre

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

109

1138

0.92

0.37

1.7

1.6

56.51

55.11

0.15

681

(4268621) Lupus anticoagulant assay

768

1.10

0.37

2.3

2.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

137

1.26

0.37

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.39

0.37

12.8

12.7

3.93

4.55

mmol/l

—

(3023410) Appearance of Cerebral spinal fluid

796

1.10

0.37

1.6

1.5

—

(3012565) Volume of 24 hour Urine

341

1.15

0.36

2.0

1.6

2026.09

1876.44

0.48

303

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

181

1.22

0.36

1.0

1.1

920.00

1026.32

titre

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

360

0.85

0.36

1.0

1.1

—

0.16

—

(40762887) Creatinine [Moles/volume] in Blood

1.27

0.36

1.3

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

155

1.24

0.36

1.5

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

421

0.87

0.35

1.0

0.62

0.59

u/ml

0.05

106

(37021550) Renin [Units/volume] in Plasma --upright

164

1.23

0.35

1.0

1.3

169.18

58.82

mu/l

0.60

116

(3038071) Oxygen [Partial pressure] in Mixed venous blood

112

1.29

0.35

8.7

7.1

7.96

5.40

kpa

0.84

112

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.35

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

370

3406

1.04

0.35

3.7

4.1

1.57

1.56

0.07

353

3231

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

203

0.80

0.34

1.4

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

703

0.90

0.34

1.4

1.81

1.40

nmol/l

1.49

634

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

325

1.15

0.34

6.3

4.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

122

1086

1.08

0.34

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

171

0.79

0.34

1.0

1.2

96.52

53.45

u/ml

0.98

166

(3019309) Folate [Moles/volume] in Red Blood Cells

1660

15657

1.02

0.34

1.8

1.7

1151.59

1193.04

nmol/l

0.95

1194

11692

(3013166) Neutrophils/Leukocytes in Synovial fluid

244

0.83

0.34

2.3

1.4

51.59

53.19

0.06

209

(3010375) cycloSPORINE [Mass/volume] in Blood

201

1.19

0.33

25.1

28.8

105.40

104.75

ug/l

0.02

161

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

308

2828

1.05

0.33

2.2

1.5

0.54

0.34

g/l

0.71

251

2375

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.69

0.33

2.0

1.9

1.23

1.64

mg/l

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

125

1117

1.08

0.32

1.2

2.61

3.76

u/ml

0.63

402

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4130

39996

0.98

0.32

2.2

99.81

100.22

pmol/l

0.19

1888

18711

(3042733) HLA Ab [Presence] in Serum

148

0.78

0.32

4.4

4.7

—

(3006653) Thiamine [Moles/volume] in Blood

373

1.13

0.31

1.2

1.3

146.48

132.82

nmol/l

0.79

373

(3023419) Bacteria identified in Sputum by Culture

107

952

1.08

0.31

2.9

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

339

3126

1.04

0.31

2.0

1.4

2.98

2.91

g/l

0.56

297

2737

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

210

0.82

0.31

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.32

0.30

1.4

1.5

—

(4146454) Self-monitoring of blood glucose

108

963

1.08

0.30

2.4

2.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

257

1.16

0.30

1.2

1.3

29.89

21.58

—

(3036670) Protein [Mass/volume] in Synovial fluid

275

1.15

0.30

1.3

40.19

38.86

g/l

0.25

143

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

110

983

1.08

0.30

1.1

1.51

1.48

g/l

0.52

101

881

(3047181) Lactate [Moles/volume] in Blood

231

2115

1.05

0.29

3.8

4.8

1.17

1.29

mmol/l

1.11

209

1859

(3028433) Virus identified in Specimen by Culture

213

1.17

0.29

1.2

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

367

1.13

0.29

1.1

1.2

51.29

59.53

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

372

0.88

0.29

1.8

2.0

327.05

122.37

umol/l

1.12

198

(4211845) Urine protein measurement

431

1.11

0.28

4.0

3.4

—

(4195642) Thrombophilia screening test

116

1041

1.07

0.28

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

241

1.16

0.28

1.0

1.1

89.50

93.00

0.21

112

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.28

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.32

0.28

1.3

1.8

83.50

49.89

umol/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

143

1.21

0.27

2.1

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

143

1.21

0.27

1.0

1.1

30.52

30.70

iu/ml

0.01

143

(40768446) Kidney Pathology biopsy report

207

0.83

0.27

1.7

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

226

2270

0.95

0.27

1.1

6.71

8.83

eliau/ml

0.34

225

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

208

1904

1.05

0.27

1.2

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

350

0.88

0.27

1.0

0.18

0.29

u/ml

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

664

6219

1.03

0.26

2.4

2.5

25.84

24.70

au/ml

0.13

641

(3025018) Bordetella pertussis Ab [Titer] in Serum

600

0.91

0.26

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

370

1.12

0.26

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

133

0.79

0.26

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

257

2369

1.04

0.26

1.1

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

719

0.92

0.26

1.5

1.6

83.87

91.11

ng/l

0.49

719

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

720

7072

0.98

0.25

2.1

2.0

3.13

3.25

ratio

2.60

553

5428

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

134

1215

1.06

0.25

1.2

1.3

468.43

307.47

pmol/l

0.38

116

1056

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

648

0.92

0.25

1.0

1.1

6.31

8.42

iu/ml

0.52

134

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

722

1.08

0.25

1.0

—

(3020491) Glucose [Moles/volume] in Blood

518

0.91

0.25

1.3

2.0

6.07

6.91

mmol/l

3.07

353

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

235

1.14

0.24

1.0

1.1

97.36

95.46

0.08

113

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

496

0.91

0.23

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

257

2376

1.04

0.23

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.33

0.23

1.8

2.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

244

2255

1.04

0.23

2.0

1.4

0.00

g/l

0.17

210

1965

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

160

1465

1.05

0.23

2.0

1.9

4285.19

4632.69

u/l

0.05

589

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

182

0.84

0.22

1.3

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.26

0.22

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

254

2351

1.04

0.22

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.75

0.22

1.7

2.9

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

6588

63008

1.01

0.22

4.6

4.8

14.12

12.81

mm/h

10.59

6052

58774

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

243

2248

1.04

0.22

3.0

1.5

1.51

1.45

ratio

0.14

128

1329

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

107

1088

0.94

0.22

1.3

1.2

30.00

48.97

u/ml

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2247

21789

0.99

0.21

4.2

4.3

0.27

0.19

0.21

259

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

3.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

27.96

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

1.40

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

1.98

—

(3008717) Parietal cell Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

397.27

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

277

2749

0.97

0.21

1.3

1.4

275.68

294.42

ug/g

0.81

158

1575

(3023511) Choriogonadotropin [Units/volume] in Urine

770

0.93

0.21

1.6

1.3

—

(3042517) Benzodiazepines panel - Urine

1.17

0.21

4.2

1.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.17

0.21

1.0

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.68

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

6.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

413

1.09

0.21

1.3

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.20

0.0

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

531

0.92

0.20

1.1

1.0

3.30

7.00

nmol/l

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

796

1.06

0.20

1.6

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.25

0.20

1.0

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

111

0.78

0.20

1.9

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

173

1729

0.96

0.19

3.8

3.7

26.96

23.08

mg/l

0.72

119

1222

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

240

0.88

0.19

1.2

1.4

124.38

135.36

nmol/l

0.12

157

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

533

5228

0.98

0.19

1.8

1.7

3.52

3.53

mmol/l

0.01

355

3612

(3002619) Bacteria identified in Specimen by Culture

222

1.12

0.19

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

351

1.09

0.19

1.4

1.5

16.80

15.55

pmol/l

0.79

293

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

354

3310

1.03

0.19

2.0

1.4

3.65

3.64

g/l

0.07

312

2928

(3006462) Nitrate [Presence] in Urine

398

1.09

0.18

3.8

3.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

519

1.07

0.18

1.1

216.90

248.84

mg/l

1.38

465

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

354

3313

1.03

0.18

2.0

1.4

4.23

4.29

g/l

0.74

312

2929

(4015189) Microbial culture of sputum

214

1.12

0.18

1.8

2.7

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

147

0.85

0.18

1.2

1.1

115.08

111.23

0.17

142

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

148

1364

1.04

0.18

1.1

10.45

18.70

au/ml

1.80

250

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

184

1831

0.96

0.18

1.2

1.3

3.56

3.74

mmol/l

1.48

174

1738

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

183

1821

0.96

0.18

1.4

809.87

1285.19

e6/l

0.61

128

1462

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

457

0.92

0.17

1.1

2.68

6.86

u/ml

—

(4094501) Cardiovascular stress test using bicycle ergometer

241

2385

0.97

0.17

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

379

3553

1.03

0.17

2.0

2.1

41.33

40.41

u/l

0.40

329

3152

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

526

0.93

0.17

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

252

2349

1.03

0.17

1.2

921.43

1004.02

titre

—

107

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

811

1.05

0.17

1.6

17.86

23.83

u/ml

1.01

173

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.74

0.17

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.73

0.17

2.2

2.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

124

1.16

0.16

1.3

1.1

0.05

0.56

u/ml

0.59

124

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

119

1094

1.04

0.16

1.2

3.29

3.57

u/ml

0.17

465

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

128

1179

1.04

0.16

1.2

—

nmol/l

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

227

2115

1.03

0.16

2.0

1.5

0.00

g/l

-0.00

208

1958

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

354

3320

1.02

0.16

2.0

1.4

7.58

7.62

g/l

0.15

312

2933

(3006442) Creatine [Moles/volume] in Serum or Plasma

466

1.07

0.16

1.4

1.6

79.58

73.99

umol/l

0.29

466

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

218

2157

0.97

0.16

1.1

1.2

5.13

3.79

0.87

230

(3027273) Bicarbonate [Moles/volume] in Venous blood

357

3507

0.98

0.16

3.0

3.1

25.51

25.71

mmol/l

0.57

349

3404

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

226

0.89

0.16

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

447

4376

0.98

0.15

2.2

2.1

2.65

0.01

estimate

0.50

1443

(3010144) Erythrocytes [#/volume] in Synovial fluid

852

1.05

0.15

1.9

1.5

146412.56

131288.42

e6/l

0.07

559

(3047007) Chlamydophila sp Ab [Presence] in Serum

129

1192

1.04

0.15

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

199

1.11

0.14

1.0

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

224

0.90

0.14

1.3

1.4

39.92

41.82

0.08

153

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

413

1.07

0.14

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

181

1.11

0.14

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

181

1.11

0.14

2.0

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

161

1498

1.03

0.13

1.1

1.2

—

(3045716) Anion gap in Serum or Plasma by calculation

818

1.04

0.13

3.2

2.6

10.46

10.54

mmol/l

0.08

808

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

127

1178

1.04

0.13

1.1

2.18

2.60

0.17

153

(44806071) Cardiolipin IgM antibody measurement

104

0.83

0.13

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

105

0.82

0.13

1.1

—

(3044941) Cell count panel - Synovial fluid

168

1660

0.97

0.13

1.6

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1754

16964

0.99

0.12

1.5

1.4

2.23

2.35

g/l

1.97

942

9699

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

499

4717

1.02

0.12

1.1

1.04

1.51

u/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

500

1.06

0.12

1.3

1.4

4.52

5.51

u/l

1.77

427

(3014271) Vancomycin [Susceptibility]

416

1.06

0.12

3.1

3.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

212

2085

0.98

0.12

3.7

4.9

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

409

3991

0.98

0.11

3.5

3.7

46.74

46.97

0.06

403

3945

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

697

6772

0.99

0.11

2.8

3.0

195.38

186.93

ng/l

0.20

642

6210

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

128

1.13

0.11

7.1

6.5

70.90

70.08

—

(3039000) Anion gap in Blood by calculation

149

1391

1.03

0.11

4.5

5.7

10.36

11.15

mmol/l

2.69

135

1240

(3018572) Chloride [Moles/volume] in Blood

149

1392

1.03

0.11

4.5

5.7

105.07

104.41

mmol/l

0.94

136

1241

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

437

1.05

0.10

2.5

2019.73

789.53

u/ml

0.51

428

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

175

1.10

0.10

1.2

1.3

1.17

1.19

mmol/l

0.42

175

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

203

1.09

0.10

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

778

0.96

0.10

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

213

1.08

0.10

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

120

1.12

0.10

1.4

2.0

0.32

0.14

e9/l

—

(3024471) HLA-A [Type]

120

1.12

0.10

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.14

0.10

1.0

—

19.36

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.14

0.10

1.0

—

20.86

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.12

0.10

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.09

0.09

1.6

353.24

545.33

nmol/l

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

305

2881

1.02

0.09

1.9

1.4

9.75

9.91

g/l

0.26

260

2468

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

273

2576

1.02

0.09

3.1

1.5

35.52

30.76

mg/l

0.46

232

2167

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.04

0.09

1.0

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2089

20154

0.99

0.09

2.5

2.1

318.31

320.62

umol/l

0.48

1795

17318

(3034860) Kappa light chains.free [Mass/volume] in Serum

274

2588

1.02

0.09

3.1

1.5

52.43

37.92

mg/l

0.93

230

2186

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

794

0.97

0.09

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.09

0.08

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

482

0.96

0.08

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

394

0.95

0.08

1.1

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

1.07

0.08

1.0

1.3

—

17.79

—

(3011985) Renin [Units/volume] in Plasma

140

1313

1.02

0.08

1.4

56.30

52.80

mu/l

0.09

126

1179

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

196

1.08

0.08

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

793

0.97

0.08

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

215

1.07

0.08

1.1

4.94

10.16

pmol/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

659

1.03

0.08

1.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

179

1686

1.02

0.08

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

295

0.94

0.08

2.1

3.2

26.79

27.33

umol/l

0.09

228

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4053

38807

1.00

0.08

3.0

3.1

118.73

94.94

ug/l

6.90

3696

35855

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

184

1798

0.98

0.07

1.4

93.75

32.76

e6/l

0.41

111

1361

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

233

2203

1.02

0.07

2.1

2.2

11.38

11.48

mg/l

0.07

217

2036

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

113

1.10

0.07

1.0

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

325

3159

0.99

0.07

1.6

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.86

0.07

1.1

2.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

506

4812

1.01

0.07

2.6

3.0

124.51

128.35

g/l

4.03

492

4673

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.04

0.07

4.6

7.1

11.18

10.11

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

104

1.11

0.07

1.0

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

107

0.90

0.06

1.0

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.11

0.06

3.0

2.9

—

29.01

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

111

1044

1.02

0.06

1.2

1.1

4.67

3.83

eliau/ml

0.17

417

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

152

1.07

0.05

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

165

0.93

0.05

1.6

2.5

6.36

7.21

mmol/l

—

104

(4027681) Cerebrospinal fluid IgG ratio and IgG index

389

0.96

0.05

1.2

0.52

0.60

ratio

1.28

241

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

682

6507

1.01

0.05

1.2

140.28

142.62

u/ml

0.05

241

2585

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

301

0.96

0.05

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

299

2842

1.01

0.05

1.8

2.0

3.89

14.96

iu/l

0.89

109

1186

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

435

0.97

0.04

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

201

1.05

0.04

1.0

1.1

—

(3033099) Centromere Ab [Titer] in Serum

258

1.04

0.04

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

620

1.02

0.04

1.1

1.0

314.95

298.14

mg/l

1.02

554

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.09

0.04

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

811

0.98

0.03

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

171

1624

1.01

0.03

1.7

1.8

307.65

326.80

mu/l

0.37

162

1440

(3015736) pH of Urine

3779

36328

1.00

0.03

3.8

3.9

6.29

0.08

2006

19868

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

945

0.99

0.03

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

249

2373

1.01

0.03

1.8

1.7

13325.50

12143.42

e6/l

0.17

179

1658

(3024932) HLA-DR beta [Type]

117

1.07

0.03

1.1

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

279

1.03

0.02

1.1

3.7

55.42

67.22

mg/l

0.62

181

(36660697) Celiac disease serology panel - Serum

780

7465

1.00

0.02

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

402

0.98

0.02

1.2

121.53

143.09

mmol/24h

1.29

402

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

825

0.99

0.01

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

305

0.98

0.01

1.5

1.1

39.99

39.63

g/l

0.13

305

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

234

2256

1.00

0.01

1.6

15.24

19.28

iu/ml

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

215

2073

1.00

0.01

1.3

565.81

506.99

mg/l

0.62

205

1972

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

205

1.03

0.01

1.0

1.2

274.18

307.19

pmol/l

0.19

138

(3045683) HLA typing for celiac disease panel - Blood or Tissue

477

0.99

0.01

1.1

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

313

0.98

0.00

1.3

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

292

1.02

0.00

1.1

99.96

96.13

0.27

217

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

111

0.95

0.00

2.1

2.9

0.82

0.81

u/field

0.01

111

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

135

1.00

0.00

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

169

1.02

0.00

1.3

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.04

0.00

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

389

1.01

0.00

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

343

1.01

0.00

1.1

85.25

537.59

ng/l

—

(3018333) Ribosomal P Ab [Presence] in Serum

752

1.00

0.00

1.2

—

(3000330) Specific gravity of Urine by Test strip

481

4615

1.00

0.00

3.1

3.7

1.02

ratio

0.71

424

4149

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

284

2727

1.00

0.00

1.6

1.7

3.25

4.12

mg/l

1.10

212

2049

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

746

1.00

0.00

1.3

0.79

1.21

u/ml

0.39

432

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

762

1.00

0.00

1.2

—

(4133840) Spirometry

143

1.01

0.00

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

160

1.02

0.00

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

108

0.98

0.00

1.1

1.2

55.64

65.29

ug/l

1.91

108

(3034426) Prothrombin time (PT)

203

0.99

0.00

1.1

26.38

27.95

1.02

203

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

100

0.96

0.00

1.1

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

545

1.00

0.00

1.1

1.2

29.62

39.90

mg/l

2.51

465

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.08

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

12.60

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

175.00

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.2

—

27.44

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

1.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.92

-0.00

1.3

1.1

164.57

86.79

titre

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.91

-0.00

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.3

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.97

-0.00

1.8

1.3

11.63

10.23

pmol/l

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

33.11

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.86

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.91

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_BREAST_ERNEG – Malignant neoplasm of breast, HER-negative

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of breast, HER-negative

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of breast, HER-negative (C3_BREAST_ERNEG)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints